EntrezGene:10664

Symbol:

CTCF

Description:

CCCTC-binding factor (zinc finger protein)

Synonyms:

NA

Species:

Human (Homo sapiens)

Xrefs:

ExpandEntrezGene:10664

Associated motifs:

JASPAR motif:MA0139.1

Show entries

Search:

Novel motif ID	Logo	Name
1		motif1_TCGNAG
2		motif2_GCTGGAGG
3		motif3_CGCTNA
4		motif4_TGTCTA
5		motif5_CAGTGT
6		motif6_AAGACT
7		motif7_CGNATC
8		motif8_CCATGN
9		motif9_ANGGCT
10		motif10_SCGGAGASN
11		motif11_GCGANT
12		motif12_ACTAAG
13		motif13_GAGGATGCK
14		motif14_TCNACG
15		motif15_ACTGTG
16		motif16_ACCAG
17		motif17_CGCTAN
18		motif18_CATCAG
19		motif19_GYTGGMC
20		motif20_TGNAGC
21		motif21_TCTTGA
22		motif22_GGMCTG
23		motif23_CGCNAT
24		motif24_AGAACT
25		motif25_GATCCN

Showing 1 to 25 of 169 entries

Previous1 2 3 4 5 6 7Next

Transcripton Factor?:

Yes

TSS regions

Show entries

Search:

TSS peak ID	Short_description
Hg19::chr16:67596336..67596353,+	p4@CTCF
Hg19::chr16:67596356..67596367,+	p5@CTCF
Hg19::chr16:67596384..67596411,+	p3@CTCF
Hg19::chr16:67596417..67596497,+	p1@CTCF
Hg19::chr16:67596498..67596520,+	p2@CTCF

Showing 1 to 5 of 5 entries

Previous1Next

View on UCSC genome browser

Mouse over to see Genome browser image, Click image to go to Genome browser

TSS expression

Search:

Sample	p1@CTCF	p2@CTCF	p3@CTCF	p4@CTCF	p5@CTCF
hepatoblastoma cell line:HuH-6.CNhs11742.10633-108I3	179.40	12.81	1.16	1.16	2.33
acute myeloid leukemia (FAB M7) cell line:MKPL-1.CNhs11888.10802-111A1	176.23	12.69	0.00	1.41	0.00
granulocyte macrophage progenitor, donor1.CNhs12519.12131-128D7	164.79	10.22	7.66	1.28	1.28
Myoblast differentiation to myotubes, day00, control donor1.CNhs13847.13469-144I4	135.51	2.85	2.85	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1.CNhs10730.10412-106B7	131.50	14.04	11.49	0.64	3.83
acute myeloid leukemia (FAB M7) cell line:M-MOK.CNhs13049.10699-109G6	115.58	8.33	2.33	1.00	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E.CNhs13060.10836-111D8	112.01	9.85	0.00	1.23	0.00
Reticulocytes, biol_rep1.CNhs13552.11931-125I5	108.75	6.80	5.04	0.44	0.22
breast carcinoma cell line:MCF7.CNhs11943.10482-107A5	103.91	6.25	3.91	3.39	2.86
Reticulocytes, biol_rep2.CNhs13553.11932-125I6	103.01	4.97	1.83	0.52	0.78
thymus, adult, pool1.CNhs10633.10027-101D9	100.18	7.17	20.67	5.62	4.91
cerebellum - adult, donor10196.CNhs13799.10173-103C2	99.18	4.58	0.00	0.00	0.00
embryonic pancreas cell line:2C6.CNhs11814.10603-108E9	99.16	9.56	2.39	1.19	0.00
embryonic pancreas cell line:1B2C6.CNhs11731.10604-108F1	99.03	5.98	3.99	0.00	0.66
osteosarcoma cell line:143B/TK^(-)neo^(R).CNhs11279.10510-107D6	95.96	9.67	4.14	0.69	0.69
glassy cell carcinoma cell line:HOKUG.CNhs11824.10688-109F4	95.93	11.55	5.19	2.83	2.36
acute myeloid leukemia (FAB M6) cell line:EEB.CNhs13059.10835-111D7	90.48	6.12	4.45	1.95	2.23
acute myeloid leukemia (FAB M4) cell line:FKH-1.CNhs13503.10830-111D2	90.23	12.53	10.03	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1.CNhs11772.10063-101H9	87.27	8.73	1.31	0.44	0.87
mesodermal tumor cell line:HIRS-BM.CNhs12191.10696-109G3	87.07	8.83	1.26	0.00	0.00
myxofibrosarcoma cell line:MFH-ino.CNhs11729.10600-108E6	86.83	11.92	1.70	1.14	0.57
rectum, fetal, donor1.CNhs11777.10067-101I4	84.01	6.39	1.83	1.83	0.91
Wilms' tumor cell line:HFWT.CNhs11728.10597-108E3	83.74	6.74	3.85	1.92	0.96
tridermal teratoma cell line:HGRT.CNhs11828.10694-109G1	83.02	1.93	0.00	0.00	0.00
appendix, adult.CNhs12842.10189-103D9	82.61	5.25	3.32	0.55	1.66
salivary acinar cells, donor3.CNhs12812.11773-123I9	80.19	5.53	4.15	0.00	0.69
rhabdomyosarcoma cell line:RMS-YM.CNhs11269.10477-106I9	79.97	8.17	1.56	0.35	0.35
Hodgkin's lymphoma cell line:HD-Mar2.CNhs11715.10435-106E3	79.02	11.04	9.27	1.77	2.21
neuroepithelioma cell line:SK-N-MC.CNhs11853.10728-110A8	78.21	6.15	2.79	0.56	0.56
Mast cell - stimulated, donor1.CNhs11073.11487-119E2	76.86	2.96	1.97	0.49	0.49
Neural stem cells, donor2.CNhs11384.11352-117H2	75.48	10.41	1.30	5.21	1.30
cerebellum, adult, donor10252.CNhs12323.10166-103B4	74.75	6.63	1.55	2.10	0.22
temporal lobe, fetal, donor1, tech_rep2.CNhs12996.10063-101H9	74.38	9.79	0.61	0.92	1.53
embryonic pancreas cell line:1C3IKEI.CNhs11733.10606-108F3	72.83	6.91	2.83	0.94	0.94
testicular germ cell embryonal carcinoma cell line:NEC14.CNhs12351.10591-108D6	72.42	4.01	4.54	2.40	1.60
parietal lobe, fetal, donor1.CNhs11782.10072-101I9	71.11	7.11	1.09	0.55	0.00
merkel cell carcinoma cell line:MKL-1.CNhs12838.10843-111E6	70.72	12.18	2.81	1.87	3.75
CD4+CD25-CD45RA- memory conventional T cells, donor3.CNhs13539.11909-125G1	70.34	2.53	2.28	0.25	1.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2.CNhs13205.11795-124C4	69.29	3.21	1.87	0.54	0.27
optic nerve, donor1.CNhs13449.10277-104E7	68.53	2.86	1.43	1.43	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3.CNhs13538.11908-125F9	68.51	2.44	3.52	1.62	0.00
CD8+ T Cells (pluriselect), donor090325, donation2.CNhs12199.12171-128I2	68.47	3.58	2.43	0.26	0.26
choriocarcinoma cell line:T3M-3.CNhs11820.10618-108G6	68.02	6.69	1.15	0.69	0.23
nasal epithelial cells, donor2.CNhs12574.12227-129F4	67.81	2.49	3.11	1.24	0.00
occipital lobe, fetal, donor1.CNhs11784.10073-102A1	66.29	6.81	0.76	1.51	0.76
lung, fetal, donor1.CNhs11680.10068-101I5	66.03	3.93	1.10	0.47	0.16
acute myeloid leukemia (FAB M5) cell line:NOMO-1.CNhs13050.10764-110E8	66.01	2.98	5.96	2.13	0.85
Mast cell, donor2.CNhs12594.11565-120D8	65.10	3.11	1.24	0.41	0.21
CD8+ T Cells (pluriselect), donor090612, donation1.CNhs12182.12201-129C5	64.96	3.75	3.75	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1.CNhs13202.11791-124B9	64.34	2.03	5.80	0.87	0.58
thymus, fetal, pool1.CNhs10650.10043-101F7	63.87	8.13	13.90	3.54	3.54
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1.CNhs13203.11793-124C2	63.03	3.18	3.01	0.67	0.67
chronic myelogenous leukemia cell line:KU812.CNhs10727.10409-106B4	62.62	5.24	1.91	0.00	0.48
neuroblastoma cell line:NH-12.CNhs11811.10555-107I6	62.47	6.01	1.20	1.31	0.44
lung adenocarcinoma cell line:PC-14.CNhs10726.10408-106B3	62.02	1.41	2.11	2.11	2.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS.CNhs10728.10410-106B5	61.51	3.97	2.21	1.06	0.44
vagina, adult.CNhs12854.10204-103F6	61.25	2.66	3.33	0.67	0.67
Mast cell, donor4.CNhs12592.11567-120E1	61.10	1.64	0.63	0.50	0.25
neuroblastoma cell line:CHP-134.CNhs11276.10508-107D4	61.01	4.22	1.28	0.64	0.00
occipital cortex - adult, donor10196.CNhs13798.10172-103C1	60.93	5.67	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2.CNhs12997.10071-101I8	60.84	4.76	0.53	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34.CNhs13504.10831-111D3	60.78	5.42	1.69	0.51	0.17
middle temporal gyrus, donor10252.CNhs12316.10156-103A3	60.56	5.81	2.07	0.97	0.83
CD19+ B Cells (pluriselect), donor090325, donation2.CNhs12175.12174-128I5	60.46	4.00	2.40	0.80	1.60
Burkitt's lymphoma cell line:DAUDI.CNhs10739.10422-106C8	60.27	6.51	11.62	3.49	2.63
CD4+ T Cells, donor2.CNhs11955.11306-117C1	60.13	2.36	1.18	0.39	0.39
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2.CNhs13813.11913-125G5	60.02	1.97	3.78	0.49	0.82
Mast cell, donor3.CNhs12593.11566-120D9	59.67	2.31	0.72	0.43	0.00
medial temporal gyrus - adult, donor10196.CNhs13809.10183-103D3	59.43	3.54	1.10	0.85	0.37
CD8+ T Cells (pluriselect), donor090325, donation1.CNhs12201.12148-128F6	59.18	5.42	1.81	0.30	0.15
occipital cortex, adult, donor10252.CNhs12320.10163-103B1	59.06	8.62	1.28	0.48	0.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1.CNhs13204.11794-124C3	58.71	2.34	3.57	0.45	0.89
diffuse large B-cell lymphoma cell line:CTB-1.CNhs11741.10631-108I1	58.57	7.12	3.83	1.28	2.01
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1.CNhs13215.11792-124C1	58.24	3.17	5.21	1.13	0.57
CD19+ B Cells, donor1.CNhs12343.11544-120B5	58.06	1.14	2.85	1.14	1.14
bone marrow stromal cell line:StromaNKtert.CNhs11931.10686-109F2	57.79	3.33	3.33	0.00	2.22
diaphragm, fetal, donor1.CNhs11779.10069-101I6	57.79	2.41	3.21	0.00	0.80
rectal cancer cell line:TT1TKB.CNhs11255.10469-106I1	57.74	7.85	1.68	1.68	0.84
CD4+CD25-CD45RA+ naive conventional T cells, donor1.CNhs13223.11784-124B2	57.68	2.82	4.00	0.59	0.15
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6.CNhs11282.10534-107G3	57.42	5.48	4.47	2.31	1.44
parietal lobe, adult, donor10252.CNhs12317.10157-103A4	57.25	4.96	1.03	0.62	0.41
epidermoid carcinoma cell line:A431.CNhs10743.10426-106D3	57.03	8.43	3.63	0.78	0.98
squamous cell carcinoma cell line:EC-GI-10.CNhs11252.10463-106H4	56.78	4.64	2.32	1.07	0.54
seminal vesicle, adult.CNhs12851.10201-103F3	56.73	2.12	0.85	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3.CNhs13057.10833-111D5	56.71	5.45	2.42	0.40	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1.CNhs12328.10818-111B8	56.49	6.54	1.18	1.02	0.47
ductal cell carcinoma cell line:KLM-1.CNhs11100.10438-106E6	56.35	7.44	4.50	0.39	1.57
CD4+ T Cells, donor1.CNhs10853.11225-116C1	56.26	2.75	2.95	0.00	0.00
stomach, fetal, donor1.CNhs11771.10062-101H8	56.24	5.11	0.73	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3.CNhs12330.10820-111C1	56.21	6.54	2.63	0.88	0.81
breast carcinoma cell line:MDA-MB-453.CNhs10736.10419-106C5	56.15	4.37	2.80	2.01	1.66
Neural stem cells, donor1.CNhs11063.11275-116H6	55.90	4.83	1.78	0.76	0.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3.CNhs13814.11917-125G9	55.82	1.93	3.32	0.83	0.55
globus pallidus, adult, donor10252.CNhs12319.10161-103A8	55.72	6.57	2.19	0.68	0.41
acute myeloid leukemia (FAB M4eo) cell line:EoL-1.CNhs13056.10832-111D4	55.56	4.18	2.57	1.61	0.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3.CNhs13812.11920-125H3	55.54	2.08	4.16	0.78	0.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed).CNhs10724.10405-106A9	55.39	3.50	3.00	2.00	1.17
synovial sarcoma cell line:HS-SY-II.CNhs11244.10441-106E9	55.22	6.31	1.42	1.42	0.47
CD8+ T Cells (pluriselect), donor090309, donation1.CNhs12176.12186-129A8	55.11	4.14	1.27	0.32	0.96
medial temporal gyrus, adult, donor10252.CNhs12310.10150-102I6	54.83	6.89	1.38	0.88	0.50
thalamus - adult, donor10196.CNhs13794.10168-103B6	54.73	0.00	1.66	0.00	0.83
neuroectodermal tumor cell line:FU-RPNT-1.CNhs11744.10637-108I7	54.42	4.46	2.13	0.85	0.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3).CNhs13738.13366-143F9	54.38	6.57	2.55	1.09	1.09
Whole blood (ribopure), donor090325, donation1.CNhs11075.12176-128I7	53.60	1.43	1.43	0.24	0.24
throat, fetal, donor1.CNhs11770.10061-101H7	53.56	2.86	1.43	0.71	0.24
vein, adult.CNhs12844.10191-103E2	53.54	4.43	4.83	2.01	0.81
Whole blood (ribopure), donor090309, donation2.CNhs11671.12180-129A2	53.52	1.53	3.82	0.00	0.76
somatostatinoma cell line:QGP-1.CNhs11869.10781-110G7	53.50	6.36	2.12	1.89	1.18
Neurons, donor1.CNhs12338.11494-119E9	53.36	6.19	2.32	1.55	0.00
pancreatic carcinoma cell line:NOR-P1.CNhs11832.10698-109G5	53.17	6.81	2.10	1.05	1.05
CD19+ B Cells, donor3.CNhs12354.11705-123B4	53.14	2.68	2.68	0.00	0.76
heart - pulmonic valve, adult.CNhs12856.10206-103F8	52.94	2.52	0.46	0.92	0.23
testicular germ cell embryonal carcinoma cell line:NEC15.CNhs12362.10593-108D8	52.93	5.97	3.03	1.56	0.83
Mast cell, donor1.CNhs12566.11563-120D6	52.92	3.43	2.03	0.79	0.26
CD19+ B Cells (pluriselect), donor090309, donation1.CNhs12177.12189-129B2	52.80	1.76	5.28	0.00	3.52
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2.CNhs12332.10822-111C3	52.71	4.27	2.30	0.90	0.99
CD4+CD25+CD45RA+ naive regulatory T cells, donor2.CNhs13235.11796-124C5	52.55	2.84	3.79	0.00	0.47
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2.CNhs13811.11916-125G8	52.52	2.31	3.59	1.28	0.51
hippocampus - adult, donor10196.CNhs13795.10169-103B7	52.49	7.16	0.00	1.59	0.00
gastrointestinal carcinoma cell line:ECC12.CNhs11738.10615-108G3	52.34	8.06	0.34	0.34	0.17
CD4+CD25-CD45RA+ naive conventional T cells, donor3.CNhs13512.11906-125F7	52.27	4.18	3.14	0.00	1.05
cerebral meninges, adult.CNhs12840.10188-103D8	52.21	4.39	0.66	1.10	0.22
sacrococcigeal teratoma cell line:HTST.CNhs11829.10695-109G2	52.11	2.41	2.41	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2.CNhs12184.12206-129D1	52.09	1.89	1.89	0.95	0.24
uterus, adult, pool1.CNhs11676.10100-102D1	51.95	2.93	1.22	0.61	0.49
brain, fetal, pool1.CNhs11797.10085-102B4	51.90	3.99	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2.CNhs12179.12194-129B7	51.88	3.28	4.92	0.55	0.55
submaxillary gland, adult.CNhs12852.10202-103F4	51.84	2.75	2.29	0.92	0.46
CD4+ T Cells, donor3.CNhs11998.11382-118B5	51.81	3.08	2.06	0.41	0.41
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2.CNhs12326.10816-111B6	51.75	8.70	2.85	1.02	1.02
spleen, adult, pool1.CNhs10631.10025-101D7	51.69	2.82	3.67	0.85	0.75
adenocarcinoma cell line:IM95m.CNhs11882.10796-110I4	51.65	4.68	1.87	0.00	0.37
testicular germ cell embryonal carcinoma cell line:NEC8.CNhs11726.10590-108D5	51.65	2.76	5.26	1.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1.CNhs12531.12151-128F9	51.63	3.41	1.71	0.85	0.85
spinal cord, fetal, donor1.CNhs11764.10056-101H2	51.56	5.07	0.85	1.27	0.42
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3.CNhs12333.10823-111C4	51.48	3.94	2.75	0.71	0.87
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2.CNhs12329.10819-111B9	51.43	6.51	1.32	0.82	0.82
spleen, fetal, pool1.CNhs10651.10044-101F8	51.37	3.87	2.00	0.32	0.77
hippocampus, adult, donor10252.CNhs12312.10153-102I9	51.21	7.22	0.68	1.23	0.95
Cardiac Myocyte, donor1.CNhs12341.11525-119I4	51.20	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252.CNhs12228.10160-103A7	51.12	6.73	0.67	0.67	0.34
Dendritic Cells - plasmacytoid, donor3.CNhs12200.11385-118B8	50.89	6.31	2.97	0.00	0.37
pineal gland - adult, donor10196.CNhs13804.10179-103C8	50.89	4.29	0.54	0.54	0.54
Neutrophils, donor2.CNhs11959.11314-117C9	50.86	5.98	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1.CNhs13054.10828-111C9	50.80	4.02	2.12	1.48	0.42
thalamus, adult, donor10252.CNhs12314.10154-103A1	50.68	4.45	1.24	1.34	0.31
CD4+CD25+CD45RA+ naive regulatory T cells, donor3.CNhs13513.11907-125F8	50.65	0.00	1.95	0.00	0.00
skeletal muscle - soleus muscle, donor1.CNhs13454.10282-104F3	50.50	1.94	1.29	0.00	0.00
spinal cord - adult, donor10196.CNhs13807.10181-103D1	50.45	1.96	0.98	1.37	0.39
CD34+ Progenitors, donor1.CNhs13227.11545-120B6	50.23	1.32	0.00	1.32	0.00
tonsil, adult, pool1.CNhs10654.10047-101G2	50.11	3.10	2.96	1.01	0.34
cervix, adult, pool1.CNhs10618.10013-101C4	50.09	1.85	1.31	1.15	0.54
skin, fetal, donor1.CNhs11774.10065-101I2	50.03	4.86	0.49	0.97	1.46
amygdala, adult, donor10252.CNhs12311.10151-102I7	49.80	6.61	1.55	1.27	0.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2.CNhs12335.10825-111C6	49.80	2.16	0.98	0.20	0.39
locus coeruleus - adult, donor10196.CNhs13808.10182-103D2	49.77	2.33	1.03	1.81	0.52
heart - mitral valve, adult.CNhs12855.10205-103F7	49.71	2.51	0.00	0.56	0.28
migratory langerhans cells, donor2.CNhs13536.11902-125F3	49.69	3.45	1.33	0.80	0.40
CD8+ T Cells, donor2.CNhs11956.11307-117C2	49.21	4.81	1.07	0.00	0.27
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived).CNhs10723.10400-106A4	48.99	3.80	3.36	0.67	1.34
Basophils, donor2.CNhs12563.12242-129H1	48.75	2.69	2.30	0.38	0.00
CD19+ B Cells, donor2.CNhs12352.11624-122B4	48.74	3.52	2.94	0.59	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1.CNhs11864.10765-110E9	48.61	3.65	2.74	0.00	0.23
oral squamous cell carcinoma cell line:HSC-3.CNhs11717.10545-107H5	48.61	4.04	2.57	0.00	0.55
Whole blood (ribopure), donor090325, donation2.CNhs11076.12177-128I8	48.54	2.47	2.47	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3.CNhs12336.10826-111C7	48.50	3.19	0.84	0.34	0.17
olfactory region, adult.CNhs12611.10195-103E6	48.44	3.07	0.65	0.48	0.32
neuroblastoma cell line:NB-1.CNhs11284.10539-107G8	48.31	3.02	2.26	2.59	0.86
ovary, adult, pool1.CNhs10626.10020-101D2	48.21	2.63	0.90	0.75	0.60
migratory langerhans cells, donor1.CNhs13535.11901-125F2	47.94	2.34	1.95	0.78	0.19
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh).CNhs10722.10399-106A3	47.93	3.38	2.77	1.54	0.92
spinal cord, adult, donor10252.CNhs12227.10159-103A6	47.82	4.16	1.19	1.19	0.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2).CNhs12824.12724-135G6	47.81	6.34	0.85	0.98	0.61
H9 Embryonic Stem cells, biol_rep3 (H9ES-3).CNhs12837.12822-136I5	47.71	7.69	2.92	0.40	0.93
Whole blood (ribopure), donor090612, donation3.CNhs11949.12184-129A6	47.59	3.17	3.97	0.00	0.79
Natural Killer Cells, donor1.CNhs10859.11230-116C6	47.48	2.96	2.36	0.00	0.00
CD8+ T Cells, donor3.CNhs11999.11383-118B6	47.36	3.77	2.32	0.58	0.72
Whole blood (ribopure), donor090309, donation3.CNhs11948.12181-129A3	47.28	1.14	0.57	0.00	1.14
medulloblastoma cell line:ONS-76.CNhs11861.10759-110E3	47.24	6.62	2.37	1.12	0.87
Neurons, donor3.CNhs13815.11655-122E8	47.21	8.29	2.55	0.64	0.00
CD19+ B Cells (pluriselect), donor090612, donation1.CNhs12183.12204-129C8	47.13	1.72	3.45	1.15	0.57
placenta, adult, pool1.CNhs10627.10021-101D3	47.10	4.35	0.98	0.71	0.27
medulla oblongata, adult, donor10252.CNhs12315.10155-103A2	47.03	4.22	2.22	1.33	0.55
parietal lobe - adult, donor10196.CNhs13797.10171-103B9	46.86	2.34	0.00	0.00	0.00
corpus callosum, adult, pool1.CNhs10649.10042-101F6	46.84	2.43	1.08	1.08	0.47
CD8+ T Cells (pluriselect), donor090612, donation3.CNhs12187.12211-129D6	46.80	2.46	2.46	0.00	0.82
small cell lung carcinoma cell line:WA-hT.CNhs11812.10562-108A4	46.80	9.51	0.75	0.45	0.45
colon, adult, donor1.CNhs11794.10082-102B1	46.78	1.99	1.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1.CNhs12334.10824-111C5	46.70	1.58	0.90	0.45	0.00
thyroid, fetal, donor1.CNhs11769.10060-101H6	46.69	2.43	1.41	0.00	0.20
lymph node, adult, donor1.CNhs11788.10077-102A5	46.64	2.48	0.99	0.00	1.49
CD14+ monocytes - mock treated, donor3.CNhs13491.11883-125D2	46.58	5.58	1.70	0.73	0.97
CD8+ T Cells (pluriselect), donor090309, donation3.CNhs12180.12196-129B9	46.57	2.85	0.95	0.00	0.95
substantia nigra, adult, donor10252.CNhs12318.10158-103A5	46.44	5.02	1.00	1.29	0.72
cerebellum, adult, pool1.CNhs11795.10083-102B2	46.40	3.25	0.89	0.59	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1.CNhs12331.10821-111C2	46.38	4.20	1.91	0.61	0.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3.CNhs12703.13163-141B4	46.36	6.87	2.58	3.43	0.00
peripheral neuroectodermal tumor cell line:KU-SN.CNhs11830.10697-109G4	46.08	6.33	3.69	2.11	1.41
Neurons, donor2.CNhs12726.11574-120E8	46.07	4.19	0.67	1.68	0.34
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3.CNhs11714.10416-106C2	45.99	5.11	8.18	1.02	2.04
pituitary gland, adult, donor10252.CNhs12229.10162-103A9	45.99	4.78	2.05	0.91	0.68
Burkitt's lymphoma cell line:RAJI.CNhs11268.10476-106I8	45.92	3.70	5.83	0.71	1.28
chronic myelogenous leukemia cell line:K562.CNhs11250.10454-106G4	45.92	1.90	0.57	0.19	0.00
Peripheral Blood Mononuclear Cells, donor1.CNhs10860.11231-116C7	45.90	1.03	2.69	0.83	0.41
Peripheral Blood Mononuclear Cells, donor3.CNhs12002.11388-118C2	45.89	2.24	1.71	0.32	0.43
prostate, adult, pool1.CNhs10628.10022-101D4	45.84	3.38	1.18	0.24	0.16
CD19+ B Cells (pluriselect), donor090612, donation3.CNhs12188.12214-129D9	45.79	3.82	0.00	0.00	0.95
gall bladder, adult.CNhs12848.10198-103E9	45.68	4.06	1.28	0.85	0.43
CD19+ B Cells (pluriselect), donor090612, donation2.CNhs12185.12209-129D4	45.61	2.64	3.31	2.64	1.98
Neutrophils, donor3.CNhs11905.11390-118C4	45.59	2.07	2.49	0.83	1.24
bladder, adult, pool1.CNhs10616.10011-101C2	45.28	1.58	0.89	1.58	0.59
caudate nucleus - adult, donor10196.CNhs13802.10177-103C6	45.17	0.89	0.00	0.00	0.89
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2.CNhs12475.13097-140D1	45.04	3.95	0.00	1.58	0.00
mucinous cystadenocarcinoma cell line:MCAS.CNhs11873.10784-110H1	45.01	8.88	3.80	0.63	1.06
occipital lobe, adult, donor1.CNhs11787.10076-102A4	44.92	3.69	1.44	0.21	0.82
carcinosarcoma cell line:JHUCS-1.CNhs11747.10642-109A3	44.80	3.65	1.22	0.17	0.17
leiomyoblastoma cell line:G-402.CNhs11848.10721-110A1	44.75	3.31	2.54	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0).CNhs12859.12760-136B6	44.69	4.03	1.37	1.28	0.37
ductus deferens, adult.CNhs12846.10196-103E7	44.59	5.13	0.79	1.18	0.39
CD19+ B Cells (pluriselect), donor090309, donation3.CNhs12181.12199-129C3	44.48	7.12	1.78	0.00	0.00
globus pallidus - adult, donor10196.CNhs13801.10175-103C4	44.43	1.80	0.60	1.20	0.00
adrenal cortex adenocarcinoma cell line:SW-13.CNhs11893.10810-111A9	44.42	4.73	1.70	0.61	0.73
smooth muscle, adult, pool1.CNhs11755.10048-101G3	44.37	3.68	1.23	0.25	0.74
CD14+CD16- Monocytes, donor3.CNhs13540.11910-125G2	44.36	2.09	1.29	0.80	0.32
acute myeloid leukemia (FAB M3) cell line:HL60.CNhs13055.10829-111D1	44.34	3.29	2.51	0.94	0.16
lung, right lower lobe, adult, donor1.CNhs11786.10075-102A3	44.32	1.24	1.66	0.41	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h).CNhs13639.13311-142I8	44.28	2.11	0.00	2.11	2.11
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL.CNhs10746.10429-106D6	44.11	5.41	2.70	0.64	0.85
lymphoma, malignant, hairy B-cell cell line:MLMA.CNhs11935.10775-110G1	44.09	5.85	3.78	1.83	1.10
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF.CNhs11825.10692-109F8	43.95	9.98	6.33	0.96	0.38
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0).CNhs12822.12627-134E8	43.92	3.95	1.98	0.70	0.46
CD4+CD25+CD45RA- memory regulatory T cells, donor1.CNhs13195.11782-124A9	43.90	2.36	3.24	0.88	0.00
cord blood derived cell line:COBL-a 24h infection(-C).CNhs11049.10452-106G2	43.89	2.37	2.97	1.19	0.30
Natural Killer Cells, donor3.CNhs12001.11387-118C1	43.64	2.70	1.03	0.39	0.00
caudate nucleus, adult, donor10252.CNhs12321.10164-103B2	43.54	2.17	0.84	1.09	0.48
CD14+ monocyte derived endothelial progenitor cells, donor3.CNhs11904.11386-118B9	43.53	2.83	1.80	0.52	0.52
acute myeloid leukemia (FAB M2) cell line:Kasumi-6.CNhs13052.10792-110H9	43.52	4.77	0.84	0.56	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2.CNhs11865.10766-110F1	43.38	3.66	0.66	0.50	0.33
throat, adult.CNhs12858.10209-103G2	43.29	2.56	0.85	0.43	0.43
Hepatocyte, donor2.CNhs12349.11603-120I1	43.24	4.91	0.98	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358.CNhs11840.10709-109H7	43.22	3.31	1.78	1.27	0.51
Endothelial Cells - Umbilical vein, donor2.CNhs11967.11324-117E1	43.11	4.04	2.25	0.67	1.12
small intestine, fetal, donor1.CNhs11773.10064-101I1	43.06	3.06	0.66	0.66	0.44
small cell lung carcinoma cell line:LK-2.CNhs11285.10541-107H1	43.03	3.39	1.69	0.79	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2.CNhs13206.11797-124C6	42.98	3.10	2.22	0.66	0.22
bile duct carcinoma cell line:TFK-1.CNhs11265.10496-107C1	42.97	5.55	1.97	1.07	1.61
Whole blood (ribopure), donor090612, donation1.CNhs11672.12182-129A4	42.80	3.24	0.00	0.00	0.65
Natural Killer Cells, donor2.CNhs11957.11311-117C6	42.69	3.02	1.51	0.22	0.22
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1.CNhs12588.12225-129F2	42.67	2.63	1.05	0.26	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat.CNhs11253.10464-106H5	42.57	6.86	5.10	1.28	0.48
Peripheral Blood Mononuclear Cells, donor2.CNhs11958.11312-117C7	42.50	1.29	2.37	0.22	0.43
colon carcinoma cell line:CACO-2.CNhs11280.10513-107D9	42.41	4.38	0.85	0.85	0.28
duodenum, fetal, donor1, tech_rep1.CNhs11781.10071-101I8	42.35	0.00	3.63	0.00	1.21
CD8+ T Cells, donor1.CNhs10854.11226-116C2	42.34	3.83	2.22	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB.CNhs10734.10417-106C3	42.29	5.03	3.10	0.30	0.15
CD133+ stem cells - adult bone marrow derived, pool1.CNhs12552.12224-129F1	42.28	4.11	0.88	0.29	0.88
CD4+CD25+CD45RA+ naive regulatory T cells, donor1.CNhs13238.11780-124A7	42.04	2.28	1.96	0.65	1.30
heart, fetal, pool1.CNhs10653.10046-101G1	41.99	3.83	1.01	0.34	0.13
uterus, fetal, donor1.CNhs11763.10055-101H1	41.91	4.07	1.22	2.44	0.81
immature langerhans cells, donor1.CNhs13537.11904-125F5	41.85	3.82	0.90	0.22	0.45
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4.CNhs13058.10834-111D6	41.81	2.74	2.34	0.98	0.98
amygdala - adult, donor10196.CNhs13793.10167-103B5	41.75	2.98	0.00	0.99	1.99
medial frontal gyrus - adult, donor10196.CNhs13796.10170-103B8	41.65	3.54	0.00	0.89	0.89
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK.CNhs10747.10430-106D7	41.64	2.68	6.55	1.89	1.34
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0).CNhs12908.12823-136I6	41.63	5.05	2.02	1.77	0.25
Whole blood (ribopure), donor090612, donation2.CNhs11673.12183-129A5	41.58	3.24	3.78	0.54	0.00
CD14+ monocytes - mock treated, donor2.CNhs13484.11873-125C1	41.57	4.91	1.51	0.00	0.00
colon, fetal, donor1.CNhs11780.10070-101I7	41.55	2.44	0.61	0.00	1.22
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2.CNhs13839.13437-144E8	41.54	4.15	2.91	1.25	0.83
Endothelial Cells - Umbilical vein, donor3.CNhs12010.11400-118D5	41.22	4.50	2.59	1.35	0.79
squamous cell lung carcinoma cell line:EBC-1.CNhs11273.10486-107A9	41.08	3.53	3.29	0.56	0.48
CD8+ T Cells (pluriselect), donor090309, donation2.CNhs12178.12191-129B4	41.02	3.26	1.30	0.00	0.65
diencephalon, adult.CNhs12610.10193-103E4	41.00	1.87	0.70	0.47	0.70
putamen, adult, donor10196.CNhs12324.10176-103C5	40.85	2.67	0.31	0.94	0.16
NK T cell leukemia cell line:KHYG-1.CNhs11867.10777-110G3	40.69	4.04	4.26	1.12	2.58
amniotic membrane cells, donor2.CNhs12503.12236-129G4	40.68	1.78	2.67	0.89	1.48
chorionic membrane cells, donor3.CNhs12380.12240-129G8	40.51	1.60	1.60	1.60	0.53
Small Airway Epithelial Cells, donor3.CNhs12016.11406-118E2	40.46	4.45	2.63	0.61	0.61
insula, adult, pool1.CNhs10646.10039-101F3	40.40	3.95	0.43	0.67	0.36
heart - tricuspid valve, adult.CNhs12857.10207-103F9	40.20	5.03	2.15	0.72	0.00
locus coeruleus, adult, donor10252.CNhs12322.10165-103B3	40.07	3.70	1.06	1.45	0.53
migratory langerhans cells, donor3.CNhs13547.11903-125F4	40.07	1.96	1.31	0.49	0.49
small intestine, adult, pool1.CNhs10630.10024-101D6	39.90	3.24	0.69	0.31	0.08
teratocarcinoma cell line:PA-1.CNhs11890.10807-111A6	39.87	6.43	3.53	0.50	0.76
small cell gastrointestinal carcinoma cell line:ECC10.CNhs11736.10610-108F7	39.79	3.98	0.80	0.00	0.40
kidney, fetal, pool1.CNhs10652.10045-101F9	39.76	4.46	0.94	1.78	0.58
SABiosciences XpressRef Human Universal Total RNA, pool1.CNhs10610.10002-101A5	39.67	2.47	1.65	0.41	0.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0).CNhs12825.12725-135G7	39.60	4.77	1.87	1.66	0.52
esophagus, adult, pool1.CNhs10620.10015-101C6	39.57	2.91	2.04	0.58	0.97
cord blood derived cell line:COBL-a 24h infection.CNhs11050.10453-106G3	39.54	2.72	2.10	0.86	0.37
CD4+CD25-CD45RA- memory conventional T cells, donor2.CNhs13237.11798-124C7	39.52	3.78	1.72	0.34	0.34
Basophils, donor3.CNhs12575.12243-129H2	39.48	2.79	2.17	0.62	0.46
adult T-cell leukemia cell line:ATN-1.CNhs10738.10421-106C7	39.45	1.78	3.12	0.89	0.45
neuroectodermal tumor cell line:FU-RPNT-2.CNhs11753.10663-109C6	39.41	4.21	1.74	0.74	0.74
Hepatocyte, donor1.CNhs12340.11523-119I2	39.29	1.27	0.00	0.00	0.00
hairy cell leukemia cell line:Mo.CNhs11843.10712-109I1	39.17	3.68	2.89	1.84	0.53
amniotic membrane cells, donor1.CNhs12502.12235-129G3	39.15	2.39	0.95	0.00	0.48
colon, adult, pool1.CNhs10619.10014-101C5	39.01	2.83	2.57	0.71	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650.CNhs11889.10805-111A4	38.85	8.02	1.06	0.21	0.00
myelodysplastic syndrome cell line:SKM-1.CNhs11934.10772-110F7	38.84	2.56	2.03	0.85	0.53
heart, adult, pool1.CNhs10621.10016-101C7	38.61	3.79	0.67	0.89	0.45
maxillary sinus tumor cell line:HSQ-89.CNhs10732.10414-106B9	38.48	4.08	2.51	1.41	1.10
Prostate Epithelial Cells (polarized), donor1.CNhs10882.11253-116F2	38.43	6.77	0.48	0.48	0.12
Dendritic Cells - plasmacytoid, donor1.CNhs10857.11228-116C4	38.40	1.67	3.34	0.00	0.24
Hepatocyte, donor3.CNhs12626.11684-122I1	38.40	2.36	0.59	0.00	0.00
amniotic membrane cells, donor3.CNhs12379.12237-129G5	38.40	2.46	2.15	1.23	0.31
blood, adult, pool1.CNhs11761.10053-101G8	38.32	2.39	0.00	0.00	0.00
skeletal muscle, fetal, donor1.CNhs11776.10066-101I3	38.27	3.48	0.00	1.16	0.00
aorta, adult, pool1.CNhs11760.10052-101G7	38.26	1.20	0.40	0.60	0.20
nucleus accumbens, adult, pool1.CNhs10644.10037-101F1	38.15	3.02	1.09	0.90	0.13
adipose tissue, adult, pool1.CNhs10615.10010-101C1	38.09	1.76	1.17	0.88	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1.CNhs10858.11229-116C5	38.07	3.58	1.79	0.45	0.45
oral squamous cell carcinoma cell line:SAS.CNhs11810.10544-107H4	38.01	6.01	2.43	0.81	0.58
lung adenocarcinoma cell line:A549.CNhs11275.10499-107C4	37.98	3.08	1.71	0.86	0.86
CD14+ monocytes - treated with B-glucan, donor2.CNhs13489.11879-125C7	37.83	4.52	2.06	0.00	0.41
brain, adult, donor1.CNhs11796.10084-102B3	37.80	0.00	0.97	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1.CNhs12325.10815-111B5	37.73	5.42	3.29	0.58	0.39
signet ring carcinoma cell line:NUGC-4.CNhs11270.10483-107A6	37.67	3.66	2.56	0.98	0.12
acute myeloid leukemia (FAB M2) cell line:Kasumi-1.CNhs13502.10788-110H5	37.66	4.87	1.95	0.65	0.65
Whole blood (ribopure), donor090309, donation1.CNhs11675.12179-129A1	37.55	3.55	2.54	0.51	0.00
pancreas, adult, donor1.CNhs11756.10049-101G4	37.51	3.13	1.56	0.78	0.00
Astrocyte - cerebral cortex, donor1.CNhs10864.11235-116D2	37.50	1.43	0.86	0.29	0.57
glioblastoma cell line:A172, tech_rep2.CNhs11248.10444-106F3	37.37	2.58	2.04	0.95	0.41
gall bladder carcinoma cell line:TGBC14TKB.CNhs11256.10470-106I2	37.35	4.50	1.17	0.20	0.20
tongue, fetal, donor1.CNhs11768.10059-101H5	37.30	3.42	2.40	0.34	0.34
parotid gland, adult.CNhs12849.10199-103F1	37.28	3.29	1.64	0.00	0.55
Fibroblast - Periodontal Ligament, donor2.CNhs11962.11319-117D5	37.16	2.38	2.00	0.38	1.25
epithelioid sarcoma cell line:HS-ES-1.CNhs11247.10443-106F2	37.15	2.41	2.75	1.38	0.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ.CNhs13051.10770-110F5	37.10	3.78	2.06	1.37	1.03
CD34+ Progenitors, donor2.CNhs12205.11625-122B5	36.99	1.12	0.56	0.00	0.00
small cell cervical cancer cell line:HCSC-1.CNhs11885.10800-110I8	36.96	3.51	2.34	1.64	0.70
trachea, fetal, donor1.CNhs11766.10058-101H4	36.93	2.00	1.33	0.33	1.00
CD14-CD16+ Monocytes, donor3.CNhs13548.11911-125G3	36.90	2.19	2.37	0.37	0.55
small cell lung carcinoma cell line:NCI-H82.CNhs12809.10842-111E5	36.83	3.96	3.63	0.88	0.77
choriocarcinoma cell line:BeWo.CNhs10740.10423-106C9	36.80	3.50	1.71	2.96	1.35
parietal lobe, adult, pool1.CNhs10641.10034-101E7	36.59	3.30	1.20	0.82	0.38
Chondrocyte - re diff, donor2.CNhs11373.11339-117F7	36.58	2.39	0.80	2.39	0.80
mesothelioma cell line:Mero-25.CNhs13066.10850-111F4	36.54	3.13	3.65	0.52	0.52
acute myeloid leukemia (FAB M6) cell line:F-36P.CNhs13505.10837-111D9	36.51	2.43	1.08	0.27	0.00
postcentral gyrus, adult, pool1.CNhs10638.10032-101E5	36.50	3.42	0.26	0.79	0.39
chronic myeloblastic leukemia (CML) cell line:KCL-22.CNhs11886.10801-110I9	36.42	4.08	1.41	0.94	0.31
embryonic kidney cell line: HEK293/SLAM untreated.CNhs11046.10450-106F9	36.39	2.49	2.38	0.93	0.52
medulloblastoma cell line:D283 Med.CNhs12805.10838-111E1	36.39	3.74	2.08	0.55	0.28
temporal lobe, adult, pool1.CNhs10637.10031-101E4	36.38	3.40	0.88	0.75	0.34
Ciliary Epithelial Cells, donor1.CNhs10871.11242-116D9	36.21	3.12	1.04	0.47	0.57
mature adipocyte, donor2.CNhs12559.12232-129F9	36.10	1.75	1.25	0.25	0.25
Universal RNA - Human Normal Tissues Biochain, pool1.CNhs10612.10007-101B4	36.06	2.92	1.69	0.56	0.38
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1.CNhs11251.10455-106G5	36.05	5.02	3.53	0.74	0.74
CD4+CD25-CD45RA- memory conventional T cells, donor1.CNhs13239.11786-124B4	36.02	1.92	3.83	0.77	0.38
tongue, adult.CNhs12853.10203-103F5	35.92	1.52	1.09	0.44	0.44
brain, adult, pool1.CNhs10617.10012-101C3	35.90	2.78	0.93	0.83	0.09
gastric adenocarcinoma cell line:MKN45.CNhs11819.10612-108F9	35.88	4.18	1.87	0.58	1.44
occipital pole, adult, pool1.CNhs10643.10036-101E9	35.82	2.42	0.35	1.11	0.28
liver, fetal, pool1.CNhs11798.10086-102B5	35.78	2.65	1.33	0.00	0.00
serous cystadenocarcinoma cell line:HTOA.CNhs11827.10693-109F9	35.68	4.47	0.67	0.78	0.56
medulla oblongata - adult, donor10196.CNhs13800.10174-103C3	35.55	3.44	1.72	0.57	0.57
Intestinal epithelial cells (polarized), donor1.CNhs10875.11246-116E4	35.54	3.32	1.72	0.37	0.00
medulla oblongata, adult, pool1.CNhs10645.10038-101F2	35.46	2.30	0.93	0.93	0.43
Basophils, donor1.CNhs12546.12241-129G9	35.40	2.36	2.75	0.79	0.79
CD14+ Monocytes, donor2.CNhs11954.11305-117B9	35.30	2.41	2.21	0.40	0.40
cord blood derived cell line:COBL-a untreated.CNhs11045.10449-106F8	35.29	2.82	1.67	0.94	0.63
kidney, adult, pool1.CNhs10622.10017-101C8	35.23	2.44	1.34	1.26	0.32
penis, adult.CNhs12850.10200-103F2	35.23	2.48	0.00	0.50	0.00
pituitary gland - adult, donor10196.CNhs13805.10180-103C9	35.20	2.43	2.43	1.82	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3.CNhs12327.10817-111B7	35.15	3.94	2.22	0.49	0.66
frontal lobe, adult, pool1.CNhs10647.10040-101F4	35.14	3.17	0.82	0.63	0.13
testis, adult, pool2.CNhs12998.10096-102C6	35.10	1.61	1.88	1.61	1.34
large cell lung carcinoma cell line:IA-LM.CNhs11277.10509-107D5	35.06	2.96	1.58	0.42	0.21
glioblastoma cell line:A172.CNhs11185.10444-106F3	35.04	2.62	1.78	0.31	0.73
eye, fetal, donor1.CNhs11762.10054-101G9	35.03	2.49	1.13	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0).CNhs12952.12858-137D5	34.98	3.38	0.99	0.66	0.58
Small Airway Epithelial Cells, donor2.CNhs11975.11334-117F2	34.98	5.00	1.73	0.58	0.38
hereditary spherocytic anemia cell line:WIL2-NS.CNhs11891.10808-111A7	34.97	5.25	1.69	0.59	1.10
skeletal muscle, adult, pool1.CNhs10629.10023-101D5	34.91	4.00	1.95	1.13	0.10
Dendritic Cells - plasmacytoid, donor2.CNhs12196.11309-117C4	34.89	2.29	1.72	0.00	0.00
transitional-cell carcinoma cell line:5637.CNhs10735.10418-106C4	34.76	4.56	1.14	0.81	0.90
retina, adult, pool1.CNhs10636.10030-101E3	34.59	2.50	0.86	0.93	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2.CNhs13822.13425-144D5	34.56	6.11	2.09	1.29	0.64
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction).CNhs12405.14329-155E9	34.44	1.08	1.08	1.26	1.61
dura mater, adult, donor1.CNhs10648.10041-101F5	34.44	1.45	1.64	0.70	0.32
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1.CNhs13826.13433-144E4	34.38	6.46	1.93	1.38	0.41
Astrocyte - cerebral cortex, donor2.CNhs11960.11316-117D2	34.36	3.28	1.23	1.23	0.41
liposarcoma cell line:SW 872.CNhs11851.10726-110A6	34.22	4.87	1.25	0.45	0.11
CD14+ monocytes - treated with Candida, donor2.CNhs13488.11878-125C6	34.21	3.23	3.23	1.29	0.00
CD14+ monocytes - mock treated, donor1.CNhs13468.11863-125A9	34.17	3.34	2.33	0.58	0.58
transitional-cell carcinoma cell line:JMSU1.CNhs11261.10492-107B6	34.15	2.13	2.77	0.75	0.53
paracentral gyrus, adult, pool1.CNhs10642.10035-101E8	34.04	3.31	1.28	0.88	0.27
trachea, adult, pool1.CNhs10635.10029-101E2	34.00	2.51	1.79	0.86	0.14
Osteoblast, donor2.CNhs11385.11354-117H4	33.88	0.66	0.66	1.99	0.66
Smooth Muscle Cells - Bronchial, donor2.CNhs12348.11592-120G8	33.81	1.71	0.43	0.43	1.71
Fibroblast - Periodontal Ligament, donor4 (PL29).CNhs12493.11223-116B8	33.80	0.88	1.32	0.88	0.88
CD14+ monocyte derived endothelial progenitor cells, donor2.CNhs11897.11310-117C5	33.68	1.62	0.65	0.32	0.65
fibrous histiocytoma cell line:GCT TIB-223.CNhs11842.10711-109H9	33.38	3.38	5.56	1.39	0.99
testicular germ cell embryonal carcinoma cell line:ITO-II.CNhs11876.10786-110H3	33.35	4.69	2.35	0.51	0.92
CD14+ monocytes - treated with Cryptococcus, donor2.CNhs13487.11877-125C5	33.29	3.55	1.36	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9.CNhs11249.10448-106F7	33.28	3.47	1.53	0.97	0.83
oral squamous cell carcinoma cell line:Ca9-22.CNhs10752.10434-106E2	33.27	4.51	1.57	0.59	0.79
Wilms' tumor cell line:G-401.CNhs11892.10809-111A8	33.22	5.13	1.82	0.53	0.75
mature adipocyte, donor1.CNhs12558.12231-129F8	33.19	1.63	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1.CNhs13541.11789-124B7	33.17	2.32	1.69	0.00	0.00
mesothelioma cell line:No36.CNhs13074.10857-111G2	33.16	3.11	3.11	1.38	1.38
lung, adult, pool1.CNhs10625.10019-101D1	33.10	1.82	2.35	0.64	0.53
teratocarcinoma cell line:NCR-G1.CNhs11884.10798-110I6	33.07	4.94	0.63	0.25	0.13
Eosinophils, donor2.CNhs12548.12245-129H4	32.95	2.64	0.00	1.32	0.00
Prostate Epithelial Cells, donor3.CNhs12014.11404-118D9	32.87	3.50	1.66	0.37	0.64
umbilical cord, fetal, donor1.CNhs11765.10057-101H3	32.85	7.04	2.35	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3.CNhs13241.10789-110H6	32.75	2.11	1.53	0.38	0.38
leukemia, chronic megakaryoblastic cell line:MEG-01.CNhs11859.10752-110D5	32.75	4.02	0.90	0.49	0.49
Sebocyte, donor1.CNhs10847.11220-116B5	32.73	2.87	2.87	0.00	0.57
Hep-2 cells mock treated, biol_rep2.CNhs13500.11899-125E9	32.71	2.87	3.03	0.84	0.84
epididymis, adult.CNhs12847.10197-103E8	32.67	1.57	0.52	0.70	0.35
granulosa cell tumor cell line:KGN.CNhs11740.10624-108H3	32.66	1.29	0.86	0.86	0.00
Fibroblast - Aortic Adventitial, donor3.CNhs12011.11401-118D6	32.63	3.19	1.06	0.71	0.35
Clontech Human Universal Reference Total RNA, pool1.CNhs10608.10000-101A1	32.55	2.29	0.92	1.18	0.33
Sebocyte, donor2.CNhs11951.11301-117B5	32.50	1.95	1.95	0.65	0.00
cervical cancer cell line:D98-AH2.CNhs11288.10552-107I3	32.35	2.61	3.38	0.54	0.87
Meningeal Cells, donor3.CNhs12731.11654-122E7	32.34	1.32	1.54	0.66	0.29
Renal Glomerular Endothelial Cells, donor3.CNhs12624.11675-122H1	32.17	1.94	1.30	0.65	0.22
choriocarcinoma cell line:SCH.CNhs11875.10785-110H2	32.16	3.04	2.50	1.41	0.76
acute myeloid leukemia (FAB M0) cell line:KG-1.CNhs13053.10827-111C8	32.13	2.79	0.60	0.60	0.40
CD14+ Monocytes, donor3.CNhs11997.11381-118B4	32.12	2.60	1.52	0.00	0.87
squamous cell carcinoma cell line:T3M-5.CNhs11739.10616-108G4	32.11	4.23	2.12	0.71	0.35
colon carcinoma cell line:COLO-320.CNhs10737.10420-106C6	32.03	4.76	1.08	1.08	0.43
embryonic kidney cell line: HEK293/SLAM infection, 24hr.CNhs11047.10451-106G1	32.02	8.72	3.01	0.60	0.60
Astrocyte - cerebral cortex, donor3.CNhs12005.11392-118C6	31.89	3.39	1.00	0.63	1.26
CD14+ monocytes - treated with B-glucan, donor1.CNhs13474.11869-125B6	31.84	3.72	1.86	0.00	0.70
Endothelial Cells - Aortic, donor1.CNhs12495.11263-116G3	31.83	4.30	1.72	0.00	0.86
Meningeal Cells, donor1.CNhs11320.11493-119E8	31.73	2.80	1.79	1.68	0.34
bronchial squamous cell carcinoma cell line:KNS-62.CNhs11862.10760-110E4	31.52	2.39	1.71	0.91	0.80
embryonic pancreas cell line:1C3D3.CNhs11732.10605-108F2	31.44	3.31	3.31	0.00	0.66
Macrophage - monocyte derived, donor3.CNhs12003.11389-118C3	31.36	2.08	1.34	0.59	0.30
alveolar cell carcinoma cell line:SW 1573.CNhs11838.10708-109H6	31.25	3.41	2.56	0.57	0.57
Endothelial Cells - Aortic, donor2.CNhs11375.11340-117F8	31.24	1.39	2.08	1.04	0.35
pleomorphic hepatocellular carcinoma cell line:SNU-387.CNhs11933.10706-109H4	31.21	1.20	1.20	0.34	0.34
rhabdomyosarcoma cell line:KYM-1.CNhs11877.10787-110H4	31.15	6.04	0.23	1.39	0.46
Osteoblast - differentiated, donor3.CNhs12035.11425-118G3	31.04	3.10	1.03	2.07	1.03
Eosinophils, donor3.CNhs12549.12246-129H5	31.02	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1.CNhs10861.11232-116C8	31.02	2.46	0.74	0.25	0.25
endometrial carcinoma cell line:OMC-2.CNhs11266.10497-107C2	31.02	3.13	0.85	0.28	0.28
acantholytic squamous carcinoma cell line:HCC1806.CNhs11844.10717-109I6	30.88	2.45	2.70	0.49	0.98
mature adipocyte, donor4.CNhs12562.12234-129G2	30.82	2.95	0.00	0.33	0.33
cervical cancer cell line:ME-180.CNhs11289.10553-107I4	30.81	4.04	2.51	0.98	0.70
Lens Epithelial Cells, donor2.CNhs12568.11609-120I7	30.72	2.43	0.93	0.35	0.23
CD14-CD16+ Monocytes, donor2.CNhs13207.11800-124C9	30.63	1.79	1.19	0.40	0.80
Hep-2 cells mock treated, biol_rep3.CNhs13501.11900-125F1	30.61	4.34	2.89	0.72	0.96
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1.CNhs11084.11282-116I4	30.54	1.34	1.25	0.45	0.36
bronchogenic carcinoma cell line:ChaGo-K-1.CNhs11841.10710-109H8	30.49	3.55	1.65	1.42	1.18
Melanocyte - light, donor2.CNhs11383.11351-117H1	30.48	2.34	3.52	1.17	1.17
epidermoid carcinoma cell line:Ca Ski.CNhs10748.10431-106D8	30.47	4.53	2.70	0.87	1.13
breast, adult, donor1.CNhs11792.10080-102A8	30.45	1.45	2.90	1.45	0.72
pons, adult, pool1.CNhs10640.10033-101E6	30.45	1.97	0.88	0.88	0.20
plasma cell leukemia cell line:ARH-77.CNhs12807.10840-111E3	30.42	4.03	4.96	1.27	0.58
Retinal Pigment Epithelial Cells, donor3.CNhs12733.11689-122I6	30.26	1.63	0.98	0.33	0.98
CD14-CD16+ Monocytes, donor1.CNhs13229.11790-124B8	30.21	2.57	2.85	0.57	0.29
Fibroblast - Cardiac, donor4.CNhs11909.11452-119A3	30.19	4.36	0.62	0.62	0.62
immature langerhans cells, donor2.CNhs13480.11905-125F6	30.18	2.32	0.77	0.00	0.77
CD14+ monocytes - treated with Cryptococcus, donor1.CNhs13472.11867-125B4	29.93	3.01	1.88	0.38	0.00
CD14+CD16- Monocytes, donor1.CNhs13224.11788-124B6	29.77	1.68	1.24	0.90	0.00
Endothelial Cells - Umbilical vein, donor1.CNhs10872.11243-116E1	29.65	1.61	2.59	0.71	0.27
Meningeal Cells, donor2.CNhs12080.11573-120E7	29.65	3.05	1.74	0.44	0.44
small-cell gastrointestinal carcinoma cell line:ECC4.CNhs11734.10609-108F6	29.63	4.23	0.94	1.41	0.94
gastric cancer cell line:AZ521.CNhs11286.10549-107H9	29.55	4.24	1.95	0.69	0.57
Skeletal Muscle Cells, donor1.CNhs11083.11281-116I3	29.48	2.03	0.19	0.58	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep3.CNhs13497.11892-125E2	29.42	4.27	2.85	1.42	0.24
Hep-2 cells treated with Streptococci strain 5448, biol_rep2.CNhs13496.11891-125E1	29.41	3.92	1.74	0.65	0.87
thyroid, adult, pool1.CNhs10634.10028-101E1	29.40	2.74	1.08	0.95	0.45
astrocytoma cell line:TM-31.CNhs10742.10425-106D2	29.25	2.45	0.61	0.10	0.41
mesothelioma cell line:Mero-95.CNhs13073.10856-111G1	29.16	2.41	0.88	0.22	0.22
CD14+CD16- Monocytes, donor2.CNhs13216.11799-124C8	29.13	0.90	1.80	0.15	0.30
merkel cell carcinoma cell line:MS-1.CNhs12839.10844-111E7	29.13	4.35	2.03	0.58	0.29
Fibroblast - Dermal, donor5.CNhs12055.11454-119A5	28.81	3.88	1.13	1.13	0.65
mesenchymal stem cell line:Hu5/E18.CNhs11718.10568-108B1	28.80	1.20	0.80	0.40	0.00
heart, adult, diseased, donor1.CNhs11758.10051-101G6	28.76	1.72	0.43	0.43	0.86
lens epithelial cell line:SRA 01/04.CNhs11750.10647-109A8	28.74	1.20	5.99	1.20	1.20
argyrophil small cell carcinoma cell line:TC-YIK.CNhs11725.10589-108D4	28.72	3.02	0.50	1.01	0.25
Melanocyte - light, donor1.CNhs11303.11274-116H5	28.65	1.53	1.91	0.38	1.15
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction).CNhs12404.14326-155E6	28.53	0.76	1.77	0.76	0.50
Melanocyte, donor2 (MC+2).CNhs13156.12739-135I3	28.53	1.50	2.10	0.90	0.30
CD14+ monocytes - treated with lipopolysaccharide, donor1.CNhs13470.11865-125B2	28.45	1.82	0.61	0.00	0.61
Endothelial Cells - Lymphatic, donor3.CNhs11906.11393-118C7	28.45	1.67	1.34	0.33	0.67
osteosarcoma cell line:HS-Os-1.CNhs11290.10558-107I9	28.45	1.99	0.99	1.19	1.19
mesothelioma cell line:NCI-H28.CNhs13061.10845-111E8	28.44	2.56	3.84	0.51	0.77
splenic lymphoma with villous lymphocytes cell line:SLVL.CNhs10741.10424-106D1	28.38	3.70	3.80	1.00	0.80
Fibroblast - Dermal, donor6.CNhs12059.11458-119A9	28.37	2.25	1.97	1.40	0.42
heart, adult, diseased post-infarction, donor1.CNhs11757.10050-101G5	28.35	3.79	1.20	0.80	0.40
Astrocyte - cerebellum, donor1.CNhs11321.11500-119F6	28.32	2.34	1.60	0.98	0.37
CD14+CD16+ Monocytes, donor3.CNhs13549.11912-125G4	28.30	0.42	2.10	0.21	0.00
tubular adenocarcinoma cell line:SUIT-2.CNhs11883.10797-110I5	28.21	1.98	1.26	0.18	0.36
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2.CNhs13483.11872-125B9	28.16	2.09	1.04	0.00	0.52
biphenotypic B myelomonocytic leukemia cell line:MV-4-11.CNhs11845.10718-109I7	28.14	2.05	2.05	0.00	0.00
Ciliary Epithelial Cells, donor3.CNhs12009.11399-118D4	28.11	2.55	0.61	0.35	0.53
Endothelial Cells - Microvascular, donor3.CNhs12024.11414-118F1	28.07	2.20	0.73	0.24	0.24
salivary gland, adult, pool1.CNhs11677.10093-102C3	27.96	2.58	0.86	1.29	0.00
prostate cancer cell line:PC-3.CNhs11243.10439-106E7	27.92	2.45	1.67	0.11	0.44
Melanocyte, donor1 (MC+1).CNhs12816.12641-134G4	27.87	2.98	1.85	0.82	0.62
Fibroblast - Choroid Plexus, donor1.CNhs11319.11492-119E7	27.85	1.66	0.61	0.30	0.00
giant cell carcinoma cell line:LU65.CNhs11274.10487-107B1	27.80	3.17	4.32	0.43	1.15
Smooth Muscle Cells - Aortic, donor1.CNhs11085.11283-116I5	27.72	0.92	1.23	0.31	0.00
Fibroblast - Dermal, donor4.CNhs12052.11450-119A1	27.71	2.23	2.35	1.53	0.59
Fibroblast - skin normal, donor2 (nuclear fraction).CNhs12582.14302-155B9	27.68	3.04	1.69	1.18	0.51
Hair Follicle Dermal Papilla Cells, donor2.CNhs11979.11348-117G7	27.66	1.93	0.64	0.00	0.00
CD14+CD16+ Monocytes, donor2.CNhs13208.11801-124D1	27.64	1.28	2.76	0.64	0.85
chorionic membrane cells, donor2.CNhs12506.12239-129G7	27.57	2.93	1.65	0.92	0.18
CD14+ monocytes - treated with B-glucan, donor3.CNhs13495.11889-125D8	27.56	4.34	1.86	0.00	0.31
CD14+ monocytes - treated with IFN + N-hexane, donor1.CNhs13466.11861-125A7	27.38	3.96	1.65	0.00	0.66
retinoblastoma cell line:Y79.CNhs11267.10475-106I7	27.34	3.95	2.05	1.11	0.32
Skeletal Muscle Satellite Cells, donor3.CNhs12008.11397-118D2	27.19	2.30	2.56	0.68	0.60
keratoacanthoma cell line:HKA-1.CNhs11880.10791-110H8	27.17	6.37	3.02	0.34	0.67
Dendritic Cells - monocyte immature derived, donor1, tech_rep2.CNhs11062.11227-116C3	27.16	1.74	1.74	0.17	0.00
glioma cell line:GI-1.CNhs10731.10413-106B8	27.16	2.60	0.29	0.29	0.58
left ventricle, adult, donor1.CNhs11789.10078-102A6	27.15	3.97	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T.CNhs11857.10737-110B8	27.02	2.72	1.87	0.85	0.85
Neutrophils, donor1.CNhs10862.11233-116C9	26.96	4.49	4.49	0.00	0.75
Melanocyte, donor3 (MC+3).CNhs13406.12837-137B2	26.87	0.86	1.43	0.00	0.57
bile duct carcinoma cell line:HuCCT1.CNhs10750.10432-106D9	26.78	3.15	3.06	0.36	0.45
hepatoma cell line:Li-7.CNhs11271.10484-107A7	26.67	1.77	0.89	0.10	0.10
Endothelial Cells - Vein, donor2.CNhs11377.11344-117G3	26.58	0.95	1.90	2.85	0.00
papillary adenocarcinoma cell line:8505C.CNhs11716.10437-106E5	26.53	2.29	1.97	0.66	0.66
Fibroblast - Conjunctival, donor1.CNhs11339.11531-120A1	26.48	2.11	0.94	0.47	0.00
clear cell carcinoma cell line:TEN.CNhs11930.10636-108I6	26.44	2.94	2.45	0.49	0.33
CD14+ monocytes - treated with IFN + N-hexane, donor3.CNhs13490.11881-125C9	26.43	2.56	0.85	0.00	0.43
Melanocyte - dark, donor3.CNhs12570.11663-122F7	26.29	3.24	2.10	0.51	0.70
b cell line:RPMI1788.CNhs10744.10427-106D4	26.22	1.97	2.58	0.86	0.62
signet ring carcinoma cell line:Kato III.CNhs10753.10436-106E4	26.21	3.14	2.16	0.59	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3.CNhs13499.11896-125E6	26.16	4.62	2.31	1.15	1.54
mesothelioma cell line:Mero-41.CNhs13067.10851-111F5	26.07	2.04	1.36	0.91	0.45
Hep-2 cells mock treated, biol_rep1.CNhs13479.11898-125E8	26.03	2.72	2.84	1.18	0.71
Endothelial Cells - Aortic, donor3.CNhs12022.11412-118E8	26.00	2.26	3.39	0.00	0.00
schwannoma cell line:HS-PSS.CNhs11183.10442-106F1	25.99	2.05	2.13	0.51	0.34
melanoma cell line:COLO 679.CNhs11281.10514-107E1	25.93	2.73	1.36	0.45	0.30
glioblastoma cell line:T98G.CNhs11272.10485-107A8	25.81	2.04	2.04	1.02	0.92
salivary acinar cells, donor2.CNhs12811.11772-123I8	25.78	1.88	1.20	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ).CNhs13276.12504-133A2	25.68	1.71	0.95	0.57	0.95
liver, adult, pool1.CNhs10624.10018-101C9	25.65	2.78	0.88	0.15	0.15
Fibroblast - Gingival, donor3.CNhs12006.11394-118C8	25.62	1.55	1.45	0.31	0.31
Smooth Muscle Cells - Tracheal, donor3.CNhs12894.11674-122G9	25.58	1.97	1.97	0.66	0.00
Fibroblast - Gingival, donor2.CNhs11961.11318-117D4	25.55	1.23	1.72	0.61	0.86
Gingival epithelial cells, donor3 (GEA15).CNhs11903.11379-118B2	25.53	1.43	2.58	0.57	0.29
Small Airway Epithelial Cells, donor3 (nuclear fraction).CNhs12583.14317-155D6	25.52	3.19	1.40	0.51	0.26
Ciliary Epithelial Cells, donor2.CNhs11966.11323-117D9	25.50	2.44	1.55	0.22	0.22
Fibroblast - Periodontal Ligament, donor3.CNhs11907.11395-118C9	25.49	1.66	1.66	0.83	0.55
CD14+ monocytes - treated with Cryptococcus, donor3.CNhs13546.11887-125D6	25.17	2.02	1.12	0.22	0.22
Fibroblast - skin dystrophia myotonica, donor3.CNhs11913.11560-120D3	25.14	2.58	1.13	0.62	0.31
Fibroblast - Dermal, donor2.CNhs11379.11346-117G5	25.10	0.57	1.14	0.57	0.57
Hepatic Stellate Cells (lipocyte), donor2.CNhs12093.11604-120I2	24.99	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3).CNhs11996.11380-118B3	24.94	1.95	1.20	0.30	0.75
CD14+ Monocytes, donor1.CNhs10852.11224-116B9	24.93	2.22	1.66	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1.CNhs13477.11890-125D9	24.93	2.43	3.53	0.44	0.44
Preadipocyte - visceral, donor2.CNhs11982.11357-117H7	24.92	1.04	0.52	1.04	0.00
lymphangiectasia cell line:DS-1.CNhs11852.10727-110A7	24.90	5.14	3.16	0.20	0.99
chorionic membrane cells, donor1.CNhs12504.12238-129G6	24.88	3.51	0.96	0.32	0.32
schwannoma cell line:HS-PSS, tech_rep2.CNhs11245.10442-106F1	24.85	1.77	1.42	0.35	0.35
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1.CNhs13099.11841-124H5	24.84	1.91	2.87	0.96	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor1.CNhs12373.11757-123H2	24.82	1.63	1.63	0.81	0.00
mature adipocyte, donor3.CNhs12560.12233-129G1	24.81	1.23	0.61	0.31	0.31
testis, adult, pool1.CNhs10632.10026-101D8	24.78	1.52	0.68	1.67	0.53
Endothelial Cells - Artery, donor2.CNhs11977.11341-117F9	24.76	3.85	2.75	0.28	0.00
prostate cancer cell line:DU145.CNhs11260.10490-107B4	24.70	3.90	1.18	0.47	0.24
mixed mullerian tumor cell line:HTMMT.CNhs11944.10689-109F5	24.57	2.29	0.98	0.33	0.33
Lens Epithelial Cells, donor1.CNhs12342.11529-119I8	24.54	1.44	0.00	0.00	0.00
Endothelial Cells - Vein, donor1.CNhs12497.11267-116G7	24.53	3.07	1.53	1.53	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction).CNhs12398.14305-155C3	24.50	0.36	1.78	0.00	0.00
Placental Epithelial Cells, donor3.CNhs12037.11427-118G5	24.49	2.12	1.81	0.91	0.91
carcinoid cell line:SK-PN-DW.CNhs11846.10719-109I8	24.49	2.04	1.17	0.00	0.58
Endothelial Cells - Aortic, donor0.CNhs10837.11207-116A1	24.45	3.18	1.79	0.20	0.20
Fibroblast - skin spinal muscular atrophy, donor2.CNhs11911.11558-120D1	24.41	1.29	0.32	0.16	0.32
CD14+ monocytes - treated with Salmonella, donor2.CNhs13485.11876-125C4	24.40	2.27	1.70	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3.CNhs11912.11559-120D2	24.38	2.32	2.12	1.01	0.30
large cell lung carcinoma cell line:NCI-H460.CNhs12806.10839-111E2	24.38	1.97	0.90	0.90	0.18
small cell lung carcinoma cell line:DMS 144.CNhs12808.10841-111E4	24.38	3.45	1.19	3.09	2.26
myxofibrosarcoma cell line:NMFH-1.CNhs11821.10684-109E9	24.30	2.21	0.92	0.92	0.37
CD14+ monocytes - treated with Group A streptococci, donor3.CNhs13492.11884-125D3	24.29	0.64	0.64	0.00	0.00
mesothelioma cell line:ACC-MESO-1.CNhs11263.10493-107B7	24.27	0.96	2.89	0.58	1.16
mesothelioma cell line:Mero-82.CNhs13069.10853-111F7	24.23	4.16	1.22	0.73	0.73
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162.CNhs11858.10744-110C6	24.20	2.80	1.00	0.40	0.60
oral squamous cell carcinoma cell line:HO-1-u-1.CNhs11287.10550-107I1	24.07	1.65	0.83	0.00	0.12
mesothelioma cell line:ACC-MESO-4.CNhs11264.10494-107B8	24.02	1.93	1.07	1.93	0.64
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction).CNhs12399.14308-155C6	24.01	1.50	1.50	0.30	0.90
Melanocyte - light, donor3.CNhs12033.11423-118G1	23.95	1.71	0.00	0.00	0.00
mesothelioma cell line:Mero-84.CNhs13072.10855-111F9	23.78	1.85	0.93	0.00	0.31
Fibroblast - Gingival, donor4 (GFH2).CNhs10848.11222-116B7	23.76	1.19	1.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562.CNhs11849.10723-110A3	23.76	3.07	1.66	0.13	0.38
Gingival epithelial cells, donor2 (GEA14).CNhs11896.11302-117B6	23.73	1.36	1.64	0.27	0.00
fibrosarcoma cell line:HT-1080.CNhs11860.10758-110E2	23.71	3.84	1.10	0.55	0.00
Fibroblast - Choroid Plexus, donor2.CNhs12344.11572-120E6	23.62	3.46	0.00	0.58	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h).CNhs13650.13323-143B2	23.61	1.00	0.50	0.00	0.50
Skeletal Muscle Cells, donor6.CNhs12060.11459-119B1	23.57	2.34	1.65	0.41	0.69
tenocyte, donor2.CNhs12640.11765-123I1	23.57	0.00	0.46	0.00	0.00
Olfactory epithelial cells, donor4.CNhs13819.11936-126A1	23.55	0.94	0.35	0.47	0.35
mesothelioma cell line:NCI-H226.CNhs13062.10846-111E9	23.54	3.86	2.89	0.39	0.96
Fibroblast - skin normal, donor1 (nuclear fraction).CNhs12403.14323-155E3	23.45	1.29	1.03	0.26	0.00
CD14+ monocytes - treated with Group A streptococci, donor2.CNhs13532.11874-125C2	23.43	3.53	2.25	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3.CNhs11878.10790-110H7	23.38	2.19	2.62	0.87	0.98
Prostate Stromal Cells, donor2.CNhs11973.11332-117E9	23.31	2.00	2.19	1.82	0.36
Fibroblast - Gingival, donor5 (GFH3).CNhs11952.11303-117B7	23.24	1.24	1.24	0.49	0.49
Endothelial Cells - Thoracic, donor1.CNhs11926.11266-116G6	23.16	3.31	1.84	0.00	0.00
Renal Glomerular Endothelial Cells, donor4.CNhs13080.11783-124B1	23.13	1.54	0.00	1.54	0.00
mucinous adenocarcinoma cell line:JHOM-1.CNhs11752.10648-109A9	23.10	2.95	0.98	1.23	0.00
Preadipocyte - breast, donor2 (nuclear fraction).CNhs12584.14320-155D9	23.02	1.23	1.23	0.46	0.31
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1.CNhs13508.11843-124H7	22.96	3.10	2.48	0.31	0.93
Tracheal Epithelial Cells, donor1.CNhs11092.11292-117A5	22.90	2.02	1.73	0.77	0.29
Fibroblast - Periodontal Ligament, donor1.CNhs10867.11238-116D5	22.89	1.68	2.02	1.18	0.67
Astrocyte - cerebellum, donor3.CNhs12117.11661-122F5	22.88	2.82	1.57	1.25	0.31
Osteoblast, donor3.CNhs12036.11426-118G4	22.86	2.95	1.66	1.11	1.11
ductal cell carcinoma cell line:MIA Paca2.CNhs11259.10488-107B2	22.82	3.40	1.46	1.21	0.97
Myoblast, donor2.CNhs11965.11322-117D8	22.81	1.03	1.44	0.62	0.21
Trabecular Meshwork Cells, donor3.CNhs12124.11693-123A1	22.75	1.75	3.50	0.35	0.35
carcinoid cell line:NCI-H1770.CNhs11834.10703-109H1	22.75	3.45	0.34	0.69	0.34
anaplastic large cell lymphoma cell line:Ki-JK.CNhs11881.10795-110I3	22.74	1.48	2.47	0.82	0.16
Nucleus Pulposus Cell, donor1.CNhs10881.11252-116F1	22.58	1.84	0.49	0.74	0.37
neurofibroma cell line:Hs 53.T.CNhs11854.10729-110A9	22.58	0.95	0.32	0.95	0.00
Sertoli Cells, donor1.CNhs10851.11255-116F4	22.50	4.82	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T.CNhs11835.10704-109H2	22.50	1.91	1.53	0.76	1.53
Mammary Epithelial Cell, donor1.CNhs11077.11273-116H4	22.48	2.60	1.88	0.99	0.36
mesothelioma cell line:NCI-H2052.CNhs13063.10847-111F1	22.44	1.94	1.41	1.41	0.71
Trabecular Meshwork Cells, donor1.CNhs11340.11532-120A2	22.39	2.28	1.52	0.38	0.76
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2.CNhs13498.11895-125E5	22.37	3.14	1.57	0.59	0.59
clear cell carcinoma cell line:JHOC-5.CNhs11745.10638-108I8	22.37	1.69	2.11	0.63	0.84
mesothelioma cell line:Mero-48a.CNhs13068.10852-111F6	22.23	1.39	1.85	0.69	0.23
Endothelial Cells - Vein, donor3.CNhs12026.11416-118F3	22.17	0.92	1.47	0.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor1.CNhs12075.11521-119H9	22.14	3.69	0.74	0.00	0.74
Placental Epithelial Cells, donor1.CNhs11079.11278-116H9	22.13	1.82	1.21	0.00	0.30
Lens Epithelial Cells, donor3.CNhs12572.11690-122I7	22.07	1.76	0.94	0.47	0.23
Nucleus Pulposus Cell, donor2.CNhs12019.11409-118E5	22.01	0.50	0.50	0.00	0.50
gastric adenocarcinoma cell line:MKN1.CNhs11737.10614-108G2	21.98	4.20	0.80	0.20	0.60
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1).CNhs11936.12260-130A1	21.94	0.72	0.87	0.43	0.14
anaplastic carcinoma cell line:8305C.CNhs10745.10428-106D5	21.93	1.67	1.22	0.78	0.33
Hair Follicle Dermal Papilla Cells, donor1.CNhs12501.11271-116H2	21.90	0.00	0.00	3.13	0.00
Smooth Muscle Cells - Umbilical Vein, donor1.CNhs12597.11541-120B2	21.80	1.43	0.86	0.14	0.29
CD14+ monocytes - treated with IFN + N-hexane, donor2.CNhs13476.11871-125B8	21.74	2.79	0.60	0.40	0.20
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2).CNhs13358.12740-135I4	21.70	1.21	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385.CNhs12193.10730-110B1	21.62	0.80	0.00	2.40	0.00
Preadipocyte - subcutaneous, donor2.CNhs11981.11356-117H6	21.59	1.70	1.39	0.46	0.77
tenocyte, donor1.CNhs12639.11763-123H8	21.58	0.37	0.37	0.37	0.37
Endothelial Cells - Lymphatic, donor1.CNhs10865.11236-116D3	21.45	1.03	1.55	0.78	0.78
Astrocyte - cerebellum, donor2.CNhs12081.11580-120F5	21.42	1.43	0.82	0.82	0.41
Chondrocyte - re diff, donor3.CNhs12021.11411-118E7	21.41	2.92	0.49	0.97	0.00
Keratinocyte - epidermal, donor3.CNhs12031.11421-118F8	21.41	1.41	1.41	0.80	0.10
pagetoid sarcoma cell line:Hs 925.T.CNhs11856.10732-110B3	21.38	3.63	1.01	0.20	0.00
Endothelial Cells - Lymphatic, donor2.CNhs11901.11317-117D3	21.35	1.07	0.71	0.71	0.00
salivary acinar cells, donor1.CNhs12810.11771-123I7	21.34	1.86	1.04	0.21	0.83
Myoblast, donor3.CNhs11908.11398-118D3	21.31	0.54	1.79	0.18	0.90
Skeletal Muscle Cells, donor4.CNhs12053.11451-119A2	21.26	2.62	1.23	0.77	0.77
Fibroblast - Cardiac, donor6.CNhs12061.11460-119B2	21.25	1.80	1.80	0.65	0.33
Fibroblast - skin normal, donor2.CNhs11914.11561-120D4	21.24	1.36	1.95	0.97	0.39
Olfactory epithelial cells, donor2.CNhs13817.11934-125I8	21.23	1.96	1.43	0.18	0.18
Amniotic Epithelial Cells, donor1.CNhs11341.11533-120A3	21.19	1.75	1.53	0.87	0.44
Skeletal Muscle Cells, donor5.CNhs12056.11455-119A6	21.18	1.69	1.54	1.38	0.77
mesenchymal precursor cell - ovarian cancer left ovary, donor2.CNhs13092.11833-124G6	21.14	1.35	2.25	0.45	0.45
gall bladder carcinoma cell line:TGBC2TKB.CNhs10733.10415-106C1	21.00	1.04	1.36	0.96	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2.CNhs13420.13230-141I8	20.95	2.06	0.00	0.34	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction).CNhs12400.14311-155C9	20.94	0.86	0.29	0.29	0.57
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1.CNhs13478.11894-125E4	20.90	1.75	1.62	0.27	0.67
neuroectodermal tumor cell line:TASK1.CNhs11866.10774-110F9	20.88	3.22	1.87	0.85	0.17
Cardiac Myocyte, donor2.CNhs12350.11605-120I3	20.79	0.00	0.67	0.00	0.00
mesothelioma cell line:NCI-H2452.CNhs13064.10848-111F2	20.78	2.20	1.18	0.84	0.34
left atrium, adult, donor1.CNhs11790.10079-102A7	20.73	2.14	1.43	0.00	0.71
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1.CNhs11350.11549-120C1	20.61	0.96	0.24	0.48	0.00
Olfactory epithelial cells, donor1.CNhs13816.11933-125I7	20.59	1.04	0.62	0.00	0.00
Osteoblast - differentiated, donor2.CNhs11980.11353-117H3	20.47	2.27	0.00	0.00	2.27
Renal Epithelial Cells, donor2.CNhs12088.11597-120H4	20.46	2.92	1.46	1.46	0.00
Prostate Stromal Cells, donor1.CNhs10883.11254-116F3	20.44	2.07	0.69	0.80	0.34
Hair Follicle Outer Root Sheath Cells, donor1.CNhs12339.11504-119G1	20.43	1.86	0.46	0.46	0.46
mesenchymal precursor cell - adipose, donor2.CNhs12364.11748-123G2	20.33	3.04	0.00	0.47	0.47
Renal Cortical Epithelial Cells, donor1.CNhs11331.11516-119H4	20.30	2.26	0.90	0.45	0.45
renal cell carcinoma cell line:OS-RC-2.CNhs10729.10411-106B6	20.30	1.51	0.43	0.22	0.43
Fibroblast - skin spinal muscular atrophy, donor1.CNhs11074.11555-120C7	20.25	1.20	0.64	0.46	0.09
mesenchymal precursor cell - cardiac, donor3.CNhs12370.11754-123G8	20.21	1.71	0.78	0.78	0.31
Preadipocyte - visceral, donor1.CNhs11082.11280-116I2	20.20	1.72	1.64	0.90	0.33
hepatic mesenchymal tumor cell line:LI90.CNhs11868.10778-110G4	20.18	1.80	1.08	0.36	0.00
Gingival epithelial cells, donor1 (GEA11).CNhs11061.11221-116B6	20.10	1.93	1.93	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor1.CNhs11353.11556-120C8	20.07	0.64	0.21	0.43	0.21
Retinal Pigment Epithelial Cells, donor1.CNhs11338.11528-119I7	20.01	0.98	0.66	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3.CNhs13544.11882-125D1	19.98	0.87	0.65	0.00	0.00
Placental Epithelial Cells, donor2.CNhs11386.11355-117H5	19.97	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2.CNhs11899.11313-117C8	19.89	1.17	0.47	0.70	0.23
xeroderma pigentosum b cell line:XPL 17.CNhs11813.10563-108A5	19.88	1.60	1.60	0.00	0.00
mesenchymal precursor cell - adipose, donor1.CNhs12363.11747-123G1	19.85	0.90	0.30	0.75	0.00
Smooth Muscle Cells - Colonic, donor2.CNhs11963.11320-117D6	19.77	1.37	1.92	0.27	0.27
meningioma cell line:HKBMM.CNhs11945.10691-109F7	19.76	1.18	0.47	0.24	0.00
Skeletal Muscle Satellite Cells, donor2.CNhs11964.11321-117D7	19.58	1.45	1.31	0.44	0.44
Osteoblast - differentiated, donor1.CNhs11311.11276-116H7	19.56	1.81	0.90	0.60	0.00
CD14+ monocytes - treated with BCG, donor2.CNhs13475.11870-125B7	19.47	2.31	1.28	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, tech_rep1.CNhs10855.11227-116C3	19.47	0.65	1.95	0.00	0.00
myeloma cell line:PCM6.CNhs11258.10474-106I6	19.46	1.89	1.38	0.52	0.34
Skeletal Muscle Satellite Cells, donor1.CNhs10869.11240-116D7	19.44	1.29	1.29	0.54	0.21
mesenchymal precursor cell - ovarian cancer left ovary, donor1.CNhs12372.11756-123H1	19.43	2.39	0.80	0.48	0.48
Hepatic Stellate Cells (lipocyte), donor1.CNhs11335.11524-119I3	19.34	1.65	0.00	0.82	0.41
Small Airway Epithelial Cells, donor1.CNhs10884.11256-116F5	19.34	1.82	0.99	0.50	0.50
Dendritic Cells - monocyte immature derived, donor3.CNhs12000.11384-118B7	19.28	0.93	0.93	0.27	0.13
Renal Proximal Tubular Epithelial Cell, donor3.CNhs12120.11676-122H2	19.25	2.69	0.22	0.90	0.45
Keratinocyte - epidermal, donor1.CNhs11064.11272-116H3	19.21	1.21	1.10	0.66	0.22
Chondrocyte - de diff, donor1.CNhs11923.11261-116G1	19.16	1.45	2.53	1.08	0.36
Fibroblast - Lymphatic, donor1.CNhs11322.11506-119G3	19.11	0.00	0.91	0.00	0.00
Renal Mesangial Cells, donor1.CNhs11333.11518-119H6	18.97	0.54	1.08	1.08	0.27
CD14+ monocytes - treated with Candida, donor3.CNhs13494.11888-125D7	18.96	4.06	1.35	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3.CNhs12127.11700-123A8	18.93	0.82	1.65	1.65	0.82
melanoma cell line:G-361.CNhs11254.10465-106H6	18.84	0.86	0.57	0.57	0.86
Endothelial Cells - Artery, donor3.CNhs12023.11413-118E9	18.81	2.93	2.09	0.21	0.63
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02).CNhs12377.11761-123H6	18.80	1.50	0.86	1.07	0.43
Synoviocyte, donor3.CNhs12050.11440-118H9	18.77	1.32	0.33	0.33	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2.CNhs12104.11627-122B7	18.72	1.04	1.04	1.04	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30).CNhs11953.11304-117B8	18.70	2.45	1.53	0.31	0.31
Bronchial Epithelial Cell, donor5.CNhs12058.11457-119A8	18.67	1.51	1.81	0.60	0.30
Endothelial Cells - Thoracic, donor2.CNhs11978.11343-117G2	18.63	1.62	0.81	0.81	1.62
Adipocyte - omental, donor1.CNhs11054.11473-119C6	18.61	1.13	0.85	0.28	0.14
Mammary Epithelial Cell, donor2.CNhs11382.11350-117G9	18.60	2.33	2.33	0.29	0.29
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G).CNhs13507.11842-124H6	18.56	1.86	0.46	0.46	0.93
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1).CNhs13157.12382-131E6	18.52	2.31	1.39	0.93	0.00
thyroid carcinoma cell line:TCO-1.CNhs11872.10783-110G9	18.50	2.69	2.92	0.11	0.34
Fibroblast - skin dystrophia myotonica, donor2.CNhs11354.11557-120C9	18.44	1.27	1.70	1.06	0.21
Adipocyte - subcutaneous, donor3.CNhs12017.11408-118E4	18.28	1.04	0.52	0.00	0.52
Renal Proximal Tubular Epithelial Cell, donor2.CNhs12087.11595-120H2	18.28	0.83	1.66	0.00	1.66
CD14+ monocytes - treated with Candida, donor1.CNhs13473.11868-125B5	18.27	2.76	1.38	0.34	0.34
mesothelioma cell line:ONE58.CNhs13075.10858-111G3	18.23	3.65	1.82	0.91	0.61
Pericytes, donor2.CNhs12079.11571-120E5	18.19	3.09	1.03	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3.CNhs13421.13231-141I9	18.18	1.35	2.02	0.34	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1).CNhs13339.12642-134G5	18.15	1.34	0.67	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB.CNhs11257.10471-106I3	18.15	0.96	0.96	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2.CNhs12367.11751-123G5	18.11	0.75	0.50	0.50	0.50
serous adenocarcinoma cell line:JHOS-2.CNhs11746.10639-108I9	18.10	1.60	4.58	0.46	0.69
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1.CNhs13467.11862-125A8	18.09	3.52	1.51	0.25	0.50
nasal epithelial cells, donor1, tech_rep1.CNhs12589.12226-129F3	18.04	4.06	1.68	0.70	0.28
Smooth Muscle Cells - Brain Vascular, donor2.CNhs11900.11315-117D1	18.03	1.90	1.58	0.00	0.00
Mallassez-derived cells, donor2.CNhs13550.11929-125I3	17.97	1.85	1.68	0.17	0.17
Synoviocyte, donor2.CNhs11992.11368-117I9	17.94	1.06	0.00	0.63	0.42
mesenchymal precursor cell - cardiac, donor2.CNhs12369.11753-123G7	17.85	1.66	0.30	0.30	0.30
Olfactory epithelial cells, donor3.CNhs13818.11935-125I9	17.82	1.10	0.95	0.16	0.16
Corneal Epithelial Cells, donor3.CNhs12123.11687-122I4	17.80	2.60	0.37	1.48	0.74
Adipocyte - subcutaneous, donor1.CNhs12494.11259-116F8	17.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1.CNhs11057.11548-120B9	17.71	1.03	0.39	0.52	0.00
mesenchymal precursor cell - bone marrow, donor1.CNhs12366.11750-123G4	17.61	1.52	0.57	1.14	0.38
Mesenchymal Stem Cells - amniotic membrane, donor1.CNhs11349.11547-120B8	17.55	1.06	2.13	0.53	0.27
endometrioid adenocarcinoma cell line:JHUEM-1.CNhs11748.10643-109A4	17.53	1.56	0.87	0.17	0.35
Renal Cortical Epithelial Cells, donor2.CNhs12728.11596-120H3	17.48	1.62	2.46	0.77	0.77
Fibroblast - skin walker warburg, donor1.CNhs11352.11554-120C6	17.46	1.19	0.34	0.68	0.17
Smooth Muscle Cells - Aortic, donor0.CNhs10838.11210-116A4	17.43	1.39	1.39	0.70	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4.CNhs13094.11836-124G9	17.42	0.83	1.24	0.83	0.83
Renal Glomerular Endothelial Cells, donor2.CNhs12086.11594-120H1	17.35	2.21	1.02	0.85	0.17
Iris Pigment Epithelial Cells, donor1.CNhs12596.11530-119I9	17.33	1.37	1.20	0.17	0.34
neuroblastoma cell line:NBsusSR.CNhs11818.10607-108F4	17.30	2.20	0.16	0.47	0.16
mesenchymal precursor cell - ovarian cancer left ovary, donor3.CNhs12376.11760-123H5	17.23	0.78	0.78	0.93	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor2.CNhs13093.11835-124G8	17.22	3.13	0.52	0.00	0.00
Pancreatic stromal cells, donor1.CNhs10877.11249-116E7	17.20	0.87	1.04	0.26	0.35
Retinal Pigment Epithelial Cells, donor0.CNhs10842.11215-116A9	17.18	2.31	0.77	0.51	0.00
Preadipocyte - omental, donor1.CNhs11065.11468-119C1	17.17	1.54	0.51	0.38	0.26
mesenchymal precursor cell - cardiac, donor4.CNhs12371.11755-123G9	17.15	1.48	0.89	1.48	0.30
Amniotic Epithelial Cells, donor3.CNhs12125.11694-123A2	17.14	1.32	0.26	0.53	0.79
Preadipocyte - breast, donor1.CNhs11052.11467-119B9	17.12	1.24	0.50	0.00	0.00
Fibroblast - Aortic Adventitial, donor1.CNhs10874.11245-116E3	17.10	1.90	0.76	0.63	0.51
Preadipocyte - visceral, donor3.CNhs12039.11429-118G7	17.08	0.81	1.51	0.35	0.35
Renal Mesangial Cells, donor3.CNhs12121.11679-122H5	17.06	1.51	1.00	0.00	1.00
Mesenchymal Stem Cells - bone marrow, donor2.CNhs12100.11616-122A5	17.02	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2.CNhs12092.11601-120H8	16.83	1.40	2.80	0.00	0.00
Renal Epithelial Cells, donor3.CNhs12732.11678-122H4	16.78	1.48	1.58	0.11	0.32
giant cell carcinoma cell line:Lu99B.CNhs10751.10433-106E1	16.77	0.50	2.24	0.50	0.75
Tracheal Epithelial Cells, donor2.CNhs11993.11369-118A1	16.76	1.34	3.35	2.68	0.00
Preadipocyte - omental, donor3.CNhs12013.11403-118D8	16.73	0.48	0.80	0.16	0.64
Smooth Muscle Cells - Colonic, donor3.CNhs12007.11396-118D1	16.73	0.94	1.53	0.47	0.47
Fibroblast - Cardiac, donor5.CNhs12057.11456-119A7	16.57	1.35	0.94	0.54	0.27
Keratinocyte - oral, donor1.CNhs10879.11251-116E9	16.57	1.85	0.56	0.37	0.46
Fibroblast - Gingival, donor1.CNhs10866.11237-116D4	16.54	1.43	0.82	0.41	0.00
CD14+ monocytes - treated with Group A streptococci, donor1.CNhs13469.11864-125B1	16.53	1.53	1.84	0.31	0.31
Endothelial Cells - Microvascular, donor1.CNhs11925.11265-116G5	16.52	1.61	1.61	0.00	0.40
Mammary Epithelial Cell, donor3.CNhs12032.11422-118F9	16.49	1.15	1.53	0.38	1.15
Mesenchymal Stem Cells - umbilical, donor1.CNhs11347.11539-120A9	16.28	1.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6.CNhs12062.11461-119B3	16.27	1.48	0.74	0.37	0.74
Fibroblast - Cardiac, donor1.CNhs12498.11268-116G8	16.26	1.12	1.12	0.00	1.12
CD14+ monocytes - treated with Salmonella, donor3.CNhs13493.11886-125D5	16.19	0.62	0.62	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32).CNhs13369.12750-136A5	16.10	1.46	1.95	0.00	0.00
Mesothelial Cells, donor3.CNhs12012.11402-118D7	16.10	1.50	0.30	0.20	0.30
mesenchymal precursor cell - adipose, donor3.CNhs12365.11749-123G3	16.09	1.66	0.00	0.55	0.00
mesenchymal precursor cell - bone marrow, donor3.CNhs13098.11840-124H4	16.02	0.00	0.89	1.78	0.89
Fibroblast - Cardiac, donor2.CNhs11378.11345-117G4	16.01	2.13	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1.CNhs11090.11289-117A2	15.99	1.10	0.00	0.00	0.55
Anulus Pulposus Cell, donor1.CNhs10876.11248-116E6	15.97	0.74	0.99	0.12	0.25
Pericytes, donor1.CNhs11317.11491-119E6	15.86	1.57	0.59	0.39	0.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h).CNhs13646.13317-143A5	15.81	2.43	2.43	0.00	0.00
Bronchial Epithelial Cell, donor4.CNhs12054.11453-119A4	15.63	0.92	2.76	0.00	0.92
Preadipocyte - subcutaneous, donor3.CNhs12038.11428-118G6	15.63	0.89	0.18	0.36	0.18
Smooth Muscle Cells - Carotid, donor1.CNhs11087.11285-116I7	15.59	1.91	0.95	0.00	0.32
mesothelioma cell line:Mero-83.CNhs13070.10854-111F8	15.58	2.69	1.43	0.36	0.00
Smooth Muscle Cells - Prostate, donor1.CNhs11920.11257-116F6	15.56	0.96	0.96	0.55	0.14
Smooth Muscle Cells - Colonic, donor1.CNhs10868.11239-116D6	15.47	1.44	1.08	0.18	0.00
Fibroblast - skin normal, donor1.CNhs11351.11553-120C5	15.45	0.93	0.93	0.74	0.19
Prostate Epithelial Cells, donor2.CNhs11972.11331-117E8	15.44	3.21	1.60	0.80	0.40
Endothelial Cells - Microvascular, donor2.CNhs11376.11342-117G1	15.21	0.76	2.28	0.00	0.76
Adipocyte - breast, donor2.CNhs11969.11327-117E4	15.20	1.28	1.50	0.86	0.43
Hair Follicle Dermal Papilla Cells, donor3.CNhs12030.11420-118F7	15.19	2.76	1.38	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3.CNhs12126.11697-123A5	15.19	1.07	1.33	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM.CNhs11894.10813-111B3	15.17	1.41	0.35	0.00	0.35
Smooth Muscle Cells - Internal Thoracic Artery, donor2.CNhs11988.11364-117I5	15.11	0.97	0.73	0.00	0.00
Fibroblast - Lymphatic, donor3.CNhs12118.11667-122G2	15.09	0.72	0.00	0.72	1.44
Mesenchymal stem cells - umbilical, donor0.CNhs12492.11214-116A8	15.05	0.79	1.58	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int.CNhs11950.10812-111B2	15.01	1.84	0.31	0.31	0.00
Mallassez-derived cells, donor1 (MZH3).CNhs12538.12142-128E9	15.00	4.69	0.94	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2.CNhs13533.11875-125C3	14.73	2.58	0.37	0.37	0.00
Cardiac Myocyte, donor3.CNhs12571.11686-122I3	14.70	2.43	0.13	0.13	0.51
Mesenchymal stem cells - adipose, donor0.CNhs10844.11217-116B2	14.66	2.28	1.63	0.65	0.00
Keratinocyte - epidermal, donor2.CNhs11381.11349-117G8	14.61	1.12	2.25	1.12	0.00
Mallassez-derived cells, donor3.CNhs13551.11930-125I4	14.60	1.56	1.28	0.14	0.43
Chondrocyte - de diff, donor2.CNhs11372.11338-117F6	14.54	1.50	0.00	1.00	0.50
mesenchymal precursor cell - ovarian cancer metastasis, donor4.CNhs13097.11838-124H2	14.47	0.76	0.38	0.38	0.00
Mesenchymal Stem Cells - hepatic, donor2.CNhs12730.11618-122A7	14.44	2.00	1.00	0.29	0.00
basal cell carcinoma cell line:TE 354.T.CNhs11932.10702-109G9	14.31	1.24	0.62	0.00	0.00
liposarcoma cell line:KMLS-1.CNhs11870.10782-110G8	14.31	1.53	0.34	0.51	1.02
Urothelial Cells, donor3.CNhs12122.11681-122H7	14.19	1.33	0.89	0.44	0.00
Tracheal Epithelial Cells, donor3.CNhs12051.11441-118I1	14.16	0.00	1.09	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1.CNhs10863.11234-116D1	14.14	0.37	1.49	0.37	0.74
cholangiocellular carcinoma cell line:HuH-28.CNhs11283.10536-107G5	14.13	2.16	1.71	0.11	0.11
Smooth Muscle Cells - Prostate, donor2.CNhs11976.11335-117F3	14.00	1.84	0.85	0.57	0.28
CD14+ monocytes - treated with BCG, donor3.CNhs13543.11880-125C8	13.95	1.42	0.71	0.00	0.24
Fibroblast - Pulmonary Artery, donor1.CNhs10878.11250-116E8	13.84	2.16	0.57	0.45	0.23
Smooth Muscle Cells - Aortic, donor2.CNhs11305.11360-117I1	13.84	0.53	1.06	0.53	0.00
Nucleus Pulposus Cell, donor3.CNhs12063.11462-119B4	13.83	0.54	0.81	0.00	0.54
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2.CNhs12105.11629-122B9	13.78	2.30	2.30	1.15	1.15
Alveolar Epithelial Cells, donor1.CNhs11325.11510-119G7	13.76	1.23	0.25	0.25	0.25
Myoblast, donor1.CNhs10870.11241-116D8	13.75	0.29	0.72	0.87	0.14
Renal Glomerular Endothelial Cells, donor1.CNhs12074.11514-119H2	13.65	3.41	3.41	1.14	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction).CNhs12402.14314-155D3	13.54	0.31	0.31	0.31	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4.CNhs13096.11837-124H1	13.54	0.80	2.39	0.00	1.59
Ewing's sarcoma cell line:Hs 863.T.CNhs11836.10705-109H3	13.42	2.48	0.00	0.50	0.00
tenocyte, donor3.CNhs12641.11768-123I4	13.41	1.30	0.43	0.43	0.43
Smooth Muscle Cells - Umbilical Artery, donor2.CNhs11991.11367-117I8	13.32	0.93	0.93	0.00	0.62
Chondrocyte - de diff, donor3.CNhs12020.11410-118E6	13.18	1.88	0.58	0.43	0.14
Renal Proximal Tubular Epithelial Cell, donor1.CNhs11330.11515-119H3	13.00	3.31	2.80	0.25	1.02
Anulus Pulposus Cell, donor2.CNhs12064.11463-119B5	12.92	0.66	0.33	0.00	0.00
Preadipocyte - omental, donor2.CNhs11902.11329-117E6	12.79	0.51	0.51	0.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1.CNhs11344.11536-120A6	12.60	2.57	0.51	1.03	0.51
Smooth Muscle Cells - Carotid, donor3.CNhs12044.11434-118H3	12.56	0.78	0.00	0.00	0.00
Renal Epithelial Cells, donor1.CNhs11332.11517-119H5	12.55	0.00	2.35	2.35	0.00
Keratocytes, donor2.CNhs12095.11607-120I5	12.48	3.12	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction).CNhs12581.14332-155F3	12.45	0.79	0.40	0.40	0.26
Keratocytes, donor1.CNhs11337.11527-119I6	12.38	1.30	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2.CNhs12375.11759-123H4	12.37	1.27	0.91	0.55	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3.CNhs13545.11885-125D4	12.34	0.63	1.27	0.32	0.00
Smooth Muscle Cells - Coronary Artery, donor3.CNhs12045.11435-118H4	12.22	0.84	0.84	0.42	0.00
Esophageal Epithelial Cells, donor1.CNhs11323.11507-119G4	12.21	0.87	0.44	0.44	0.00
CD14+ monocytes - treated with Salmonella, donor1.CNhs13471.11866-125B3	12.19	0.87	1.16	0.00	0.29
Prostate Stromal Cells, donor3.CNhs12015.11405-118E1	12.19	0.92	0.39	0.26	0.26
Smooth Muscle Cells - Aortic, donor3.CNhs11309.11432-118H1	12.18	0.87	2.61	0.87	0.00
Fibroblast - Cardiac, donor3.CNhs12027.11417-118F4	12.09	0.99	0.49	0.00	0.25
Smooth Muscle Cells - Uterine, donor3.CNhs11927.11466-119B8	12.06	1.77	1.77	0.71	0.35
leiomyoma cell line:10964C.CNhs11722.10569-108B2	11.95	0.54	1.09	0.00	0.00
mesenchymal precursor cell - cardiac, donor1.CNhs12368.11752-123G6	11.90	1.83	0.46	0.00	0.46
Preadipocyte - perirenal, donor1.CNhs12065.11469-119C2	11.87	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3.CNhs12049.11439-118H8	11.83	1.13	1.13	0.00	0.00
Preadipocyte - breast, donor2.CNhs11971.11328-117E5	11.79	0.56	1.40	0.00	0.00
Mesothelial Cells, donor1.CNhs10850.11247-116E5	11.76	0.30	0.60	0.30	0.30
Endothelial Cells - Artery, donor1.CNhs12496.11264-116G4	11.75	2.10	2.10	0.42	0.42
Smooth Muscle Cells - Esophageal, donor1.CNhs11324.11508-119G5	11.70	3.41	0.98	0.49	0.00
Adipocyte - omental, donor3.CNhs12068.11475-119C8	11.62	0.89	0.45	0.45	0.00
Urothelial Cells, donor1.CNhs11334.11520-119H8	11.62	0.43	0.43	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3.CNhs12378.11762-123H7	11.57	1.80	0.30	0.15	0.30
Hair Follicle Outer Root Sheath Cells, donor2.CNhs12347.11584-120F9	11.55	0.72	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1.CNhs13465.11860-125A6	11.51	0.58	0.86	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1.CNhs11091.11290-117A3	11.36	0.81	0.81	0.20	0.20
Adipocyte - perirenal, donor1.CNhs12069.11476-119C9	11.34	1.74	0.00	0.87	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2.CNhs11989.11365-117I6	11.30	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor1.CNhs12499.11269-116G9	11.24	0.94	0.94	0.62	0.31
leiomyoma cell line:15242A.CNhs11723.10570-108B3	11.23	0.86	0.00	0.86	1.73
Mesenchymal Stem Cells - adipose, donor3.CNhs12922.11698-123A6	10.99	2.54	0.00	0.00	1.69
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31).CNhs13349.12652-134H6	10.95	0.00	0.73	0.00	0.73
Mesenchymal stem cells - hepatic, donor0.CNhs10845.11218-116B3	10.66	2.13	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2.CNhs12084.11590-120G6	10.47	0.70	1.40	0.00	0.70
Fibroblast - Dermal, donor3.CNhs12028.11418-118F5	10.46	1.20	0.75	0.30	0.15
Mesothelial Cells, donor2.CNhs12197.12156-128G5	10.46	0.87	0.87	0.87	1.74
Smooth Muscle Cells - Tracheal, donor1.CNhs11329.11513-119H1	10.42	1.16	0.00	0.00	0.00
Urothelial cells, donor0.CNhs10843.11216-116B1	9.88	0.92	1.84	0.69	0.23
Smooth Muscle Cells - Umbilical Vein, donor2.CNhs12569.11621-122B1	9.82	1.47	0.29	0.00	0.20
leiomyoma cell line:15425.CNhs11724.10571-108B4	9.80	0.33	0.33	0.33	0.33
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction).CNhs12401.14313-155D2	9.76	0.46	0.00	0.46	0.00
Smooth Muscle Cells - Brachiocephalic, donor1.CNhs11086.11284-116I6	9.64	2.04	1.11	0.74	0.19
Smooth Muscle Cells - Coronary Artery, donor2.CNhs11987.11363-117I4	9.51	0.00	1.59	0.00	0.00
Corneal Epithelial Cells, donor1.CNhs11336.11526-119I5	9.11	0.36	0.73	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3.CNhs12043.11433-118H2	9.02	1.72	0.43	0.43	0.29
Adipocyte - omental, donor2.CNhs12067.11474-119C7	9.01	1.00	3.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3.CNhs12004.11391-118C5	8.96	0.76	0.57	0.19	0.57
Smooth Muscle Cells - Umbilical artery, donor0.CNhs10839.11212-116A6	8.92	0.71	1.07	0.36	0.71
Smooth Muscle Cells - Subclavian Artery, donor3.CNhs12048.11438-118H7	8.77	0.88	0.44	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1.CNhs12374.11758-123H3	8.51	1.60	0.53	0.53	0.00
Urothelial Cells, donor2.CNhs12091.11600-120H7	8.42	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2.CNhs11371.11336-117F4	8.21	1.26	1.90	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1.CNhs11088.11286-116I8	8.09	1.21	0.81	0.20	0.20
Smooth Muscle Cells - Subclavian Artery, donor2.CNhs11990.11366-117I7	7.96	0.66	0.66	0.66	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3.CNhs12046.11436-118H5	7.40	0.00	1.06	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1.CNhs11328.11512-119G9	7.17	0.26	0.77	0.26	0.26
Adipocyte - breast, donor1.CNhs11051.11376-118A8	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1.CNhs11345.11537-120A7	0.00	0.00	0.00	0.00	0.00

Showing 1 to 889 of 889 entries

0

50

100

150

200

Click each plot point to find sample in table

ENCODE TF ChIP-seq peak enrichment analysis Analyst: Erik Arner Summary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. link to source dataset. data

(#promoters = Number of promoters in the coexpression cluster that have ChIP signal of the TF)

Show entries

Search:

Coexpression cluster	#promoters	Enrichment	p-value	q-value
C22-CD4-CD8-Natural-Basophils-CD14-Peripheral-CD19	194	1.36e+0	3.25e-6	1.09e-4
C392-Monocytederived-CD14-Macrophage-CD14CD16-Dendritic-Eosinophils-migratory	12	2.38e+0	1.87e-3	1.10e-2
C875-Eosinophils-Neutrophils-Mast-CD19-CD14-Basophils-Peripheral	6	3.57e+0	2.10e-3	1.22e-2
C890-CD19-CD4-Peripheral-CD8-Natural-Dendritic-Mast	6	3.57e+0	2.10e-3	1.22e-2
C891-Fibroblast-occipital-mesothelioma-cholangiocellular-neuroblastoma-pineal-hippocampus	6	3.57e+0	2.10e-3	1.22e-2
C943-Mesenchymal-Preadipocyte-Fibroblast-Adipocyte-Synoviocyte-Hair-Mesothelial	6	3.57e+0	2.10e-3	1.22e-2
C175-Eosinophils-Neutrophils-CD4-Basophils-CD19-CD8-Natural	35	1.88e+0	8.15e-5	1.23e-3
C111-medulla-lung-trachea-testis-caudate-epididymis-throat	53	1.65e+0	8.43e-5	1.27e-3
C151-CD14-Natural-Basophils-CD8-Eosinophils-CD4-Mast	34	1.61e+0	2.23e-3	1.28e-2
C467-CD14-Monocytederived-Mesenchymal-Macrophage-Dendritic-mucinous-liver	12	3.06e+0	9.62e-5	1.37e-3

Showing 1 to 10 of 639 entries

Previous1 2 3 4 5…64Next

DetailsSummary:It includes sequences from the international sequence collaboration, Swiss-Prot, and RefSeq. The RefSeq subset of this file is also available as gene2refseq. links to source dataset. human mouse

GeneID:	10664
LocusTag:	-
chromosome:	16
map location:	16q21-q22.3
type of gene:	protein-coding
Symbol from nomenclature authority:	CTCF
Full name from nomenclature authority:	CCCTC-binding factor (zinc finger protein)
Nomenclature status:	O
Other designations:	11 zinc finger transcriptional repressor, 11-zinc finger protein, CTCFL paralog, transcriptional repressor CTCF, 11 zinc finger transcriptional repressor;;11-zinc finger protein;;CTCFL paralog;;transcriptional repressor CTCF
Modification date:	08.01.2012

Personal tools

EntrezGene:10664 - resource_browser

Search

Human

Mouse

Rat

Dog

Chicken

Macaque

Cross species

Other

Tools

EntrezGene:10664

From FANTOM5_SSTAR

	FAQ
	Mozilla Cavendish skin modified by DaSch for the Web Community Wiki GitHub project page – Report a bug – Skin version: 2.6.0